1
|
Vogt RL, Heck PR, Watts DJ, Chabris CF, Meyer MN. Experiment aversion does generalize, but it can also be mitigated. Proc Natl Acad Sci U S A 2024; 121:e2315439121. [PMID: 38696483 DOI: 10.1073/pnas.2315439121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/04/2024] Open
Affiliation(s)
- Randi L Vogt
- Department of Bioethics and Decision Sciences, Geisinger, Danville, PA 17822
| | - Patrick R Heck
- Department of Bioethics and Decision Sciences, Geisinger, Danville, PA 17822
| | - Duncan J Watts
- Department of Computer and Information Science, University of Pennsylvania, Pennsylvania, PA 19104
- Annenberg School of Communication, University of Pennsylvania, Pennsylvania, PA 19104
- Operations, Information, and Decisions Department, University of Pennsylvania, Pennsylvania, PA 19104
| | | | - Michelle N Meyer
- Department of Bioethics and Decision Sciences, Geisinger, Danville, PA 17822
| |
Collapse
|
2
|
Meyer MN, Papageorge NW, Parens E, Regenberg A, Sugarman J, Thom K. Potential corporate uses of polygenic indexes: Starting a conversation about the associated ethics and policy issues. Am J Hum Genet 2024; 111:833-840. [PMID: 38701744 DOI: 10.1016/j.ajhg.2024.03.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2023] [Revised: 03/11/2024] [Accepted: 03/13/2024] [Indexed: 05/05/2024] Open
Abstract
Some commercial firms currently sell polygenic indexes (PGIs) to individual consumers, despite their relatively low predictive power. It might be tempting to assume that because the predictive power of many PGIs is so modest, other sorts of firms-such as those selling insurance and financial services-will not be interested in using PGIs for their own purposes. We argue to the contrary. We build this argument in two ways. First, we offer a very simple model, rooted in economic theory, of a profit-maximizing firm that can gain information about a single consumer's genome. We use the model to show that, depending on the specific economic environment, a firm would be willing to pay for statistically noisy PGIs, even if they allow for only a small reduction in uncertainty. Second, we describe two plausible scenarios in which these different kinds of firms could conceivably use PGIs to maximize profits. Finally, we briefly discuss some of the associated ethics and policy issues. They deserve more attention, which is unlikely to be given until it is first recognized that firms whose services affect a large swath of the public will indeed have incentives to use PGIs.
Collapse
Affiliation(s)
- Michelle N Meyer
- Department of Bioethics and Decision Sciences, Geisinger College of Health Sciences, Danville, PA, USA.
| | | | | | - Alan Regenberg
- Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA
| | - Jeremy Sugarman
- Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
| | - Kevin Thom
- Department of Economics, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
| |
Collapse
|
3
|
Goren A, Santos HC, Davis TW, Lowe RB, Monfette M, Meyer MN, Chabris CF. Comparison of Clinical Decision Support Tools to Improve Pediatric Lipid Screening. J Pediatr 2024; 269:113973. [PMID: 38401785 DOI: 10.1016/j.jpeds.2024.113973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Revised: 02/12/2024] [Accepted: 02/16/2024] [Indexed: 02/26/2024]
Abstract
OBJECTIVE To test whether different clinical decision support tools increase clinician orders and patient completions relative to standard practice and each other. STUDY DESIGN A pragmatic, patient-randomized clinical trial in the electronic health record was conducted between October 2019 and April 2020 at Geisinger Health System in Pennsylvania, with 4 arms: care gap-a passive listing recommending screening; alert-a panel promoting and enabling lipid screen orders; both; and a standard practice-no guideline-based notification-control arm. Data were analyzed for 13 346 9- to 11-year-old patients seen within Geisinger primary care, cardiology, urgent care, or nutrition clinics, or who had an endocrinology visit. Principal outcomes were lipid screening orders by clinicians and completions by patients within 1 week of orders. RESULTS Active (care gap and/or alert) vs control arm patients were significantly more likely (P < .05) to have lipid screening tests ordered and completed, with ORs ranging from 1.67 (95% CI 1.28-2.19) to 5.73 (95% CI 4.46-7.36) for orders and 1.54 (95% CI 1.04-2.27) to 2.90 (95% CI 2.02-4.15) for completions. Alerts, with or without care gaps listed, outperformed care gaps alone on orders, with odds ratios ranging from 2.92 (95% CI 2.32-3.66) to 3.43 (95% CI 2.73-4.29). CONCLUSIONS Electronic alerts can increase lipid screening orders and completions, suggesting clinical decision support can improve guideline-concordant screening. The study also highlights electronic record-based patient randomization as a way to determine relative effectiveness of support tools. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT04118348.
Collapse
Affiliation(s)
- Amir Goren
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA.
| | - Henri C Santos
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA
| | - Thomas W Davis
- Department of Internal Medicine, Geisinger Health System, Danville, PA
| | - Robert B Lowe
- Department of Internal Medicine, Geisinger Health System, Danville, PA
| | - Mariya Monfette
- Clinical Informatics, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA
| | - Michelle N Meyer
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA; Department of Bioethics and Decision Sciences, Geisinger College of Health Sciences, Geisinger Health System, Danville, PA
| | - Christopher F Chabris
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA; Department of Bioethics and Decision Sciences, Geisinger College of Health Sciences, Geisinger Health System, Danville, PA
| |
Collapse
|
4
|
Zhang S, Heck PR, Meyer MN, Chabris CF, Goldstein DG, Hofman JM. An illusion of predictability in scientific results: Even experts confuse inferential uncertainty and outcome variability. Proc Natl Acad Sci U S A 2023; 120:e2302491120. [PMID: 37556500 PMCID: PMC10438372 DOI: 10.1073/pnas.2302491120] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Accepted: 06/26/2023] [Indexed: 08/11/2023] Open
Abstract
Traditionally, scientists have placed more emphasis on communicating inferential uncertainty (i.e., the precision of statistical estimates) compared to outcome variability (i.e., the predictability of individual outcomes). Here, we show that this can lead to sizable misperceptions about the implications of scientific results. Specifically, we present three preregistered, randomized experiments where participants saw the same scientific findings visualized as showing only inferential uncertainty, only outcome variability, or both and answered questions about the size and importance of findings they were shown. Our results, composed of responses from medical professionals, professional data scientists, and tenure-track faculty, show that the prevalent form of visualizing only inferential uncertainty can lead to significant overestimates of treatment effects, even among highly trained experts. In contrast, we find that depicting both inferential uncertainty and outcome variability leads to more accurate perceptions of results while appearing to leave other subjective impressions of the results unchanged, on average.
Collapse
Affiliation(s)
- Sam Zhang
- Department of Applied Mathematics, University of Colorado, Boulder, CO80309
| | - Patrick R. Heck
- Office of Research, Consumer Financial Protection Bureau, Washington, DC20552
| | - Michelle N. Meyer
- Department of Bioethics & Decision Sciences, Geisinger Health System, Danville, PA17822
| | | | | | | |
Collapse
|
5
|
Meyer MN, Basl J, Choffnes D, Wilson C, Lazer DMJ. Enhancing the ethics of user-sourced online data collection and sharing. Nat Comput Sci 2023; 3:660-664. [PMID: 38177316 DOI: 10.1038/s43588-023-00490-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2024]
Affiliation(s)
- Michelle N Meyer
- Department of Bioethics and Decision Sciences, Geisinger Health System, Danville, PA, USA
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA, USA
| | - John Basl
- Department of Philosophy and Religion, Northeastern University, Boston, MA, USA
- Ethics Institute, Northeastern University, Boston, MA, USA
| | - David Choffnes
- Khoury College of Computer Sciences, Northeastern University, Boston, MA, USA
- Cybersecurity and Privacy Institute, Northeastern University, Boston, MA, USA
| | - Christo Wilson
- Khoury College of Computer Sciences, Northeastern University, Boston, MA, USA
- Cybersecurity and Privacy Institute, Northeastern University, Boston, MA, USA
| | - David M J Lazer
- Khoury College of Computer Sciences, Northeastern University, Boston, MA, USA.
- College of Social Sciences and Humanities, Northeastern University, Boston, MA, USA.
- Network Science Institute, Northeastern University, Boston, MA, USA.
- The Institute for Quantitative Social Science, Harvard University, Cambridge, MA, USA.
| |
Collapse
|
6
|
Vogt RL, Heck PR, Mestechkin RM, Heydari P, Chabris CF, Meyer MN. Experiment aversion among clinicians and the public - an obstacle to evidence-based medicine and public health. medRxiv 2023:2023.04.05.23288189. [PMID: 37066423 PMCID: PMC10104223 DOI: 10.1101/2023.04.05.23288189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/18/2023]
Abstract
Background Randomized controlled trials (RCTs) are essential for determining the safety and efficacy of healthcare interventions. However, both laypeople and clinicians often demonstrate experiment aversion: preferring to implement either of two interventions for everyone rather than comparing them to determine which is best. We studied whether clinician and layperson views of pragmatic RCTs for Covid-19 or other interventions became more positive early in the pandemic, which increased both the urgency and public discussion of RCTs. Methods We conducted several survey studies with laypeople (total n=2,909) and two with clinicians (n=895; n=1,254) in 2020 and 2021. Participants read vignettes in which a hypothetical decision-maker who sought to improve health could choose to implement intervention A for all, implement intervention B for all, or experimentally compare A and B and implement the superior intervention. Participants rated and ranked the appropriateness of each decision. Results Compared to our pre-pandemic results, we found no decrease in laypeople's aversion to non-Covid-19 experiments involving catheterization checklists and hypertension drugs. Nor were either laypeople or clinicians less averse to Covid-19 RCTs (concerning corticosteroid drugs, vaccines, intubation checklists, proning, school reopening, and mask protocols), on average. Across all vignettes and samples, levels of experiment aversion ranged from 28% to 57%, while levels of experiment appreciation (in which the RCT is rated higher than the participant's highest-rated intervention) ranged from only 6% to 35%. Conclusions Advancing evidence-based medicine through pragmatic RCTs will require anticipating and addressing experiment aversion among both patients and healthcare professionals.
Collapse
Affiliation(s)
- Randi L. Vogt
- Department of Bioethics & Decision Sciences, Geisinger
| | | | | | - Pedram Heydari
- Department of Bioethics & Decision Sciences, Geisinger
- Department of Economics, University of Pittsburgh
| | | | | |
Collapse
|
7
|
Patel MS, Milkman KL, Gandhi L, Graci HN, Gromet D, Ho H, Kay JS, Lee TW, Rothschild J, Akinola M, Beshears J, Bogard JE, Buttenheim A, Chabris C, Chapman GB, Choi JJ, Dai H, Fox CR, Goren A, Hilchey MD, Hmurovic J, John LK, Karlan D, Kim M, Laibson D, Lamberton C, Madrian BC, Meyer MN, Modanu M, Nam J, Rogers T, Rondina R, Saccardo S, Shermohammed M, Soman D, Sparks J, Warren C, Weber M, Berman R, Evans CN, Lee SH, Snider CK, Tsukayama E, Van den Bulte C, Volpp KG, Duckworth AL. A Randomized Trial of Behavioral Nudges Delivered Through Text Messages to Increase Influenza Vaccination Among Patients With an Upcoming Primary Care Visit. Am J Health Promot 2023; 37:324-332. [PMID: 36195982 PMCID: PMC10798571 DOI: 10.1177/08901171221131021] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
PURPOSE To evaluate if nudges delivered by text message prior to an upcoming primary care visit can increase influenza vaccination rates. DESIGN Randomized, controlled trial. SETTING Two health systems in the Northeastern US between September 2020 and March 2021. SUBJECTS 74,811 adults. INTERVENTIONS Patients in the 19 intervention arms received 1-2 text messages in the 3 days preceding their appointment that varied in their format, interactivity, and content. MEASURES Influenza vaccination. ANALYSIS Intention-to-treat. RESULTS Participants had a mean (SD) age of 50.7 (16.2) years; 55.8% (41,771) were female, 70.6% (52,826) were White, and 19.0% (14,222) were Black. Among the interventions, 5 of 19 (26.3%) had a significantly greater vaccination rate than control. On average, the 19 interventions increased vaccination relative to control by 1.8 percentage points or 6.1% (P = .005). The top performing text message described the vaccine to the patient as "reserved for you" and led to a 3.1 percentage point increase (95% CI, 1.3 to 4.9; P < .001) in vaccination relative to control. Three of the top five performing messages described the vaccine as "reserved for you." None of the interventions performed worse than control. CONCLUSIONS Text messages encouraging vaccination and delivered prior to an upcoming appointment significantly increased influenza vaccination rates and could be a scalable approach to increase vaccination more broadly.
Collapse
Affiliation(s)
- Mitesh S. Patel
- Department of Clinical Transformation and Behavioral Insights, Ascension, St. Louis, MO, USA
| | - Katherine L. Milkman
- Department of Operations, Information and Decisions, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| | - Linnea Gandhi
- Department of Operations, Information and Decisions, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| | - Heather N. Graci
- Behavior Change for Good Initiative, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| | - Dena Gromet
- Behavior Change for Good Initiative, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| | - Hung Ho
- Department of Marketing, The University of Chicago Booth School of Business, Chicago, IL, USA
| | - Joseph S. Kay
- Behavior Change for Good Initiative, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| | - Timothy W. Lee
- School of Professional Studies, Northwestern University, Evanston, IL, USA
| | - Jake Rothschild
- Behavior Change for Good Initiative, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| | - Modupe Akinola
- Department of Management, Columbia Business School, Columbia University, New York, NY, USA
| | - John Beshears
- Negotiation, Organizations & Markets Unit, Harvard Business School, Harvard University, Boston, MA, USA
| | - Jonathan E. Bogard
- Department of Behavioral Decision Making, Anderson School of Management, University of California, Los Angeles, CA, USA
| | - Alison Buttenheim
- Department of Family and Community Health, The University of Pennsylvania School of Nursing, Philadelphia, PA, USA
| | - Christopher Chabris
- Behavioral and Decision Sciences Program, Geisinger Health System, Danville, PA, USA
| | - Gretchen B. Chapman
- Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, PA, USA
| | - James J. Choi
- Department of Finance, Yale School of Management, Yale University, New Haven, CT, USA
| | - Hengchen Dai
- Department of Management and Organization, Anderson School of Management, University of California Los Angeles, Los Angeles, CA, USA
| | - Craig R. Fox
- Department of Management and Organization, Anderson School of Management, University of California Los Angeles, Los Angeles, CA, USA
| | - Amir Goren
- Behavioral Insights Team, Geisinger Health System, Danville, PA, USA
| | - Matthew D. Hilchey
- Department of Behavioural Science and Economics, University of Toronto, Toronto, ON, Canada
| | - Jillian Hmurovic
- Department of Marketing, Drexel University, Philadelphia, PA, USA
| | - Leslie K. John
- Negotiation, Organizations & Markets Unit, Harvard Business School, Harvard University, Boston, MA, USA
| | - Dean Karlan
- Department of Finance, Kellogg School of Management, Northwestern University, Evanston, IL, USA
| | - Melanie Kim
- Department of Behavioural Science and Economics, University of Toronto, Toronto, ON, Canada
| | - David Laibson
- Negotiation, Organizations & Markets Unit, Harvard Business School, Harvard University, Boston, MA, USA
| | - Cait Lamberton
- Department of Marketing, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| | - Brigitte C. Madrian
- Department of Finance, Marriott School of Business, Brigham Young University, Provo, UT, USA
| | - Michelle N. Meyer
- Behavioral and Decision Sciences Program, Geisinger Health System, Danville, PA, USA
| | - Maria Modanu
- Department of Management, Columbia Business School, Columbia University, New York, NY, USA
| | - Jimin Nam
- Negotiation, Organizations & Markets Unit, Harvard Business School, Harvard University, Boston, MA, USA
| | - Todd Rogers
- Negotiation, Organizations & Markets Unit, Harvard Business School, Harvard University, Boston, MA, USA
| | - Renante Rondina
- Department of Behavioural Science and Economics, University of Toronto, Toronto, ON, Canada
| | - Silvia Saccardo
- Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, PA, USA
| | - Maheen Shermohammed
- Behavioral and Decision Sciences Program, Geisinger Health System, Danville, PA, USA
| | - Dilip Soman
- Department of Behavioural Science and Economics, University of Toronto, Toronto, ON, Canada
| | - Jehan Sparks
- Department of Behavioral Decision Making, Anderson School of Management, University of California, Los Angeles, CA, USA
| | - Caleb Warren
- Department of Marketing, Eller College of Management, University of Arizona, Tucson, AZ, USA
| | - Megan Weber
- Department of Behavioral Decision Making, Anderson School of Management, University of California, Los Angeles, CA, USA
| | - Ron Berman
- Department of Marketing, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| | - Chalanda N. Evans
- Center for Digital Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Seung Hyeong Lee
- Negotiation, Organizations & Markets Unit, Harvard Business School, Harvard University, Boston, MA, USA
| | - Christopher K. Snider
- Center for Health Care Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Eli Tsukayama
- Business Administration Division, University of Hawaiì-West Òahu, Kapolei, HI, USA
| | | | - Kevin G. Volpp
- Penn Center for Health Incentives and Behavioral Economics, Departments of Medical Ethics and Health Policy and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Angela L. Duckworth
- Department of Operations, Information and Decisions, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
8
|
Meyer MN, Appelbaum PS, Benjamin DJ, Callier SL, Comfort N, Conley D, Freese J, Garrison NA, Hammonds EM, Harden KP, Lee SSJ, Martin AR, Martschenko DO, Neale BM, Palmer RHC, Tabery J, Turkheimer E, Turley P, Parens E. Wrestling with Social and Behavioral Genomics: Risks, Potential Benefits, and Ethical Responsibility. Hastings Cent Rep 2023; 53 Suppl 1:S2-S49. [PMID: 37078667 PMCID: PMC10433733 DOI: 10.1002/hast.1477] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/21/2023]
Abstract
In this consensus report by a diverse group of academics who conduct and/or are concerned about social and behavioral genomics (SBG) research, the authors recount the often-ugly history of scientific attempts to understand the genetic contributions to human behaviors and social outcomes. They then describe what the current science-including genomewide association studies and polygenic indexes-can and cannot tell us, as well as its risks and potential benefits. They conclude with a discussion of responsible behavior in the context of SBG research. SBG research that compares individuals within a group according to a "sensitive" phenotype requires extra attention to responsible conduct and to responsible communication about the research and its findings. SBG research (1) on sensitive phenotypes that (2) compares two or more groups defined by (a) race, (b) ethnicity, or (c) genetic ancestry (where genetic ancestry could easily be misunderstood as race or ethnicity) requires a compelling justification to be conducted, funded, or published. All authors agree that this justification at least requires a convincing argument that a study's design could yield scientifically valid results; some authors would additionally require the study to have a socially favorable risk-benefit profile.
Collapse
|
9
|
Martschenko DO, Callier SL, Garrison NA, Lee SSJ, Turley P, Meyer MN, Parens E. Wrestling with Public Input on an Ethical Analysis of Scientific Research. Hastings Cent Rep 2023; 53 Suppl 1:S50-S65. [PMID: 37079856 DOI: 10.1002/hast.1478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/22/2023]
Abstract
Bioethicists frequently call for empirical researchers to engage participants and community members in their research, but don't themselves typically engage community members in their normative research. In this article, we describe an effort to include members of the public in normative discussions about the risks, potential benefits, and ethical responsibilities of social and behavioral genomics (SBG) research. We reflect on what might-and might not- be gained from engaging the public in normative scholarship and on lessons learned about public perspectives on the risks and potential benefits of SBG research and the responsible conduct and communication of such research. We also provide procedural lessons for others in bioethics who are interested in engaging members of the public in their research.
Collapse
|
10
|
Abstract
Understanding moral acceptability and willingness to use is crucial for informing policy.
Collapse
Affiliation(s)
- Michelle N Meyer
- Department of Bioethics and Decision Sciences, Geisinger Health System, Danville, PA 17822, USA
- Geisinger Commonwealth School of Medicine, Scranton, PA 18510, USA
| | - Tammy Tan
- National Bureau of Economic Research, Cambridge, MA 02138, USA
| | - Daniel J Benjamin
- National Bureau of Economic Research, Cambridge, MA 02138, USA
- Anderson School of Management, University of California Los Angeles, Los Angeles, CA 90095, USA
- David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA
| | - David Laibson
- National Bureau of Economic Research, Cambridge, MA 02138, USA
- Department of Economics, Harvard University, Cambridge, MA 02138, USA
| | - Patrick Turley
- National Bureau of Economic Research, Cambridge, MA 02138, USA
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA 90089, USA
- Department of Economics, University of Southern California, Los Angeles, CA 90089, USA
| |
Collapse
|
11
|
Wolk DM, Lanyado A, Tice AM, Shermohammed M, Kinar Y, Goren A, Chabris CF, Meyer MN, Shoshan A, Abedi V. Prediction of Influenza Complications: Development and Validation of a Machine Learning Prediction Model to Improve and Expand the Identification of Vaccine-Hesitant Patients at Risk of Severe Influenza Complications. J Clin Med 2022; 11:jcm11154342. [PMID: 35893436 PMCID: PMC9332321 DOI: 10.3390/jcm11154342] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2022] [Revised: 07/11/2022] [Accepted: 07/14/2022] [Indexed: 12/02/2022] Open
Abstract
Influenza vaccinations are recommended for high-risk individuals, but few population-based strategies exist to identify individual risks. Patient-level data from unvaccinated individuals, stratified into retrospective cases (n = 111,022) and controls (n = 2,207,714), informed a machine learning model designed to create an influenza risk score; the model was called the Geisinger Flu-Complications Flag (GFlu-CxFlag). The flag was created and validated on a cohort of 604,389 unique individuals. Risk scores were generated for influenza cases; the complication rate for individuals without influenza was estimated to adjust for unrelated complications. Shapley values were used to examine the model’s correctness and demonstrate its dependence on different features. Bias was assessed for race and sex. Inverse propensity weighting was used in the derivation stage to correct for biases. The GFlu-CxFlag model was compared to the pre-existing Medial EarlySign Flu Algomarker and existing risk guidelines that describe high-risk patients who would benefit from influenza vaccination. The GFlu-CxFlag outperformed other traditional risk-based models; the area under curve (AUC) was 0.786 [0.783−0.789], compared with 0.694 [0.690−0.698] (p-value < 0.00001). The presence of acute and chronic respiratory diseases, age, and previous emergency department visits contributed most to the GFlu-CxFlag model’s prediction. When higher numerical scores were assigned to more severe complications, the GFlu-CxFlag AUC increased to 0.828 [0.823−0.833], with excellent discrimination in the final model used to perform the risk stratification of the population. The GFlu-CxFlag can better identify high-risk individuals than existing models based on vaccination guidelines, thus creating a population-based risk stratification for individual risk assessment and deployment in vaccine hesitancy reduction programs in our health system.
Collapse
Affiliation(s)
- Donna M. Wolk
- Department of Laboratory Medicine, Diagnostic Medicine Institute, Geisinger, Danville, PA 17822, USA;
- Geisinger Commonwealth School of Medicine, Scranton, PA 18509, USA
- Correspondence:
| | - Alon Lanyado
- Medial EarlySign, 6 Hangar Road, Hod Hasharon 4527703, Israel; (A.L.); (Y.K.); (A.S.)
| | - Ann Marie Tice
- Department of Laboratory Medicine, Diagnostic Medicine Institute, Geisinger, Danville, PA 17822, USA;
| | - Maheen Shermohammed
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger, Danville, PA 17822, USA; (M.S.); (A.G.); (C.F.C.); (M.N.M.)
| | - Yaron Kinar
- Medial EarlySign, 6 Hangar Road, Hod Hasharon 4527703, Israel; (A.L.); (Y.K.); (A.S.)
| | - Amir Goren
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger, Danville, PA 17822, USA; (M.S.); (A.G.); (C.F.C.); (M.N.M.)
| | - Christopher F. Chabris
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger, Danville, PA 17822, USA; (M.S.); (A.G.); (C.F.C.); (M.N.M.)
| | - Michelle N. Meyer
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger, Danville, PA 17822, USA; (M.S.); (A.G.); (C.F.C.); (M.N.M.)
| | - Avi Shoshan
- Medial EarlySign, 6 Hangar Road, Hod Hasharon 4527703, Israel; (A.L.); (Y.K.); (A.S.)
| | - Vida Abedi
- Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA 17033, USA;
| |
Collapse
|
12
|
Wagner JK, Tanniru JK, Chane CA, Meyer MN. Exploring access to genomic risk information and the contours of the HIPAA public health exception. J Law Biosci 2022; 9:lsac034. [PMID: 36518815 PMCID: PMC9740515 DOI: 10.1093/jlb/lsac034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 09/28/2022] [Indexed: 06/17/2023]
Abstract
Considerable resources have been invested in research to identify pathogenic and likely pathogenic variants that cause morbidity and mortality and also in returning these results to patients. The public health impact and cost-effectiveness of these efforts are maximized when probands' relatives are informed of their risk and offered testing. However, such 'Traceback' cascade testing programs face multiple obstacles, including perceived or actual legal and regulatory hurdles. Here, using genetic cancer syndromes as a test case, we explore the contours of the Public Health Exception to the HIPAA Privacy Rule to assess whether it is a viable pathway for implementing a Traceback program. After examining the Privacy Rule as well as state laws and regulations for reportable conditions and genetic privacy, we conclude that this is not currently a viable approach for Traceback programs. We conclude by reflecting on ethical considerations of leveraging HIPAA's public health exception to disclose PHI directly to at-risk relatives and offering insights for how legal hurdles to such a Traceback program could be overcome, if desired.
Collapse
|
13
|
Okbay A, Wu Y, Wang N, Jayashankar H, Bennett M, Nehzati SM, Sidorenko J, Kweon H, Goldman G, Gjorgjieva T, Jiang Y, Hicks B, Tian C, Hinds DA, Ahlskog R, Magnusson PKE, Oskarsson S, Hayward C, Campbell A, Porteous DJ, Freese J, Herd P, Watson C, Jala J, Conley D, Koellinger PD, Johannesson M, Laibson D, Meyer MN, Lee JJ, Kong A, Yengo L, Cesarini D, Turley P, Visscher PM, Beauchamp JP, Benjamin DJ, Young AI. Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat Genet 2022; 54:437-449. [PMID: 35361970 PMCID: PMC9005349 DOI: 10.1038/s41588-022-01016-z] [Citation(s) in RCA: 161] [Impact Index Per Article: 80.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2021] [Accepted: 01/20/2022] [Indexed: 12/14/2022]
Abstract
We conduct a genome-wide association study (GWAS) of educational attainment (EA) in a sample of ~3 million individuals and identify 3,952 approximately uncorrelated genome-wide-significant single-nucleotide polymorphisms (SNPs). A genome-wide polygenic predictor, or polygenic index (PGI), explains 12-16% of EA variance and contributes to risk prediction for ten diseases. Direct effects (i.e., controlling for parental PGIs) explain roughly half the PGI's magnitude of association with EA and other phenotypes. The correlation between mate-pair PGIs is far too large to be consistent with phenotypic assortment alone, implying additional assortment on PGI-associated factors. In an additional GWAS of dominance deviations from the additive model, we identify no genome-wide-significant SNPs, and a separate X-chromosome additive GWAS identifies 57.
Collapse
Affiliation(s)
- Aysu Okbay
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
| | - Yeda Wu
- Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia
| | - Nancy Wang
- National Bureau of Economic Research, Cambridge, MA, USA
| | | | | | | | - Julia Sidorenko
- Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia
| | - Hyeokmoon Kweon
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - Grant Goldman
- National Bureau of Economic Research, Cambridge, MA, USA
| | | | | | | | | | | | - Rafael Ahlskog
- Department of Government, Uppsala University, Uppsala, Sweden
| | - Patrik K E Magnusson
- Swedish Twin Registry, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Sven Oskarsson
- Department of Government, Uppsala University, Uppsala, Sweden
| | - Caroline Hayward
- MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK
| | - Archie Campbell
- Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK
- Usher Institute, University of Edinburgh, Edinburgh, UK
| | - David J Porteous
- Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK
- Usher Institute, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK
| | - Jeremy Freese
- Department of Sociology, Stanford University, Stanford, CA, USA
| | - Pamela Herd
- McCourt School of Public Policy, Georgetown University, Washington, DC, USA
| | - Chelsea Watson
- UCLA Anderson School of Management, Los Angeles, CA, USA
| | - Jonathan Jala
- UCLA Anderson School of Management, Los Angeles, CA, USA
| | - Dalton Conley
- Department of Sociology, Princeton University, Princeton, NJ, USA
| | - Philipp D Koellinger
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
- Robert M. La Follette School of Public Affairs, University of Wisconsin-Madison, Madison, WI, USA
| | - Magnus Johannesson
- Department of Economics, Stockholm School of Economics, Stockholm, Sweden
| | - David Laibson
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA, USA
| | - James J Lee
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, MN, USA
| | - Augustine Kong
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK
| | - Loic Yengo
- Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia
| | - David Cesarini
- National Bureau of Economic Research, Cambridge, MA, USA
- Department of Economics, New York University, New York, NY, USA
- Center for Experimental Social Science, New York University, New York, NY, USA
| | - Patrick Turley
- Department of Economics, University of Southern California, Los Angeles, CA, USA
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Peter M Visscher
- Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia.
| | - Jonathan P Beauchamp
- Interdisciplinary Center for Economic Science and Department of Economics, George Mason University, Fairfax, VA, USA
| | - Daniel J Benjamin
- National Bureau of Economic Research, Cambridge, MA, USA.
- UCLA Anderson School of Management, Los Angeles, CA, USA.
- Human Genetics Department, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
| | - Alexander I Young
- UCLA Anderson School of Management, Los Angeles, CA, USA.
- Human Genetics Department, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
| |
Collapse
|
14
|
Awad E, Levine S, Anderson M, Anderson SL, Conitzer V, Crockett MJ, Everett JAC, Evgeniou T, Gopnik A, Jamison JC, Kim TW, Liao SM, Meyer MN, Mikhail J, Opoku-Agyemang K, Borg JS, Schroeder J, Sinnott-Armstrong W, Slavkovik M, Tenenbaum JB. Computational ethics. Trends Cogn Sci 2022; 26:388-405. [PMID: 35365430 DOI: 10.1016/j.tics.2022.02.009] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2021] [Revised: 02/14/2022] [Accepted: 02/25/2022] [Indexed: 12/11/2022]
Abstract
Technological advances are enabling roles for machines that present novel ethical challenges. The study of 'AI ethics' has emerged to confront these challenges, and connects perspectives from philosophy, computer science, law, and economics. Less represented in these interdisciplinary efforts is the perspective of cognitive science. We propose a framework - computational ethics - that specifies how the ethical challenges of AI can be partially addressed by incorporating the study of human moral decision-making. The driver of this framework is a computational version of reflective equilibrium (RE), an approach that seeks coherence between considered judgments and governing principles. The framework has two goals: (i) to inform the engineering of ethical AI systems, and (ii) to characterize human moral judgment and decision-making in computational terms. Working jointly towards these two goals will create the opportunity to integrate diverse research questions, bring together multiple academic communities, uncover new interdisciplinary research topics, and shed light on centuries-old philosophical questions.
Collapse
Affiliation(s)
- Edmond Awad
- Department of Economics, University of Exeter, Exeter, UK; Institute for Data Science and AI, University of Exeter, Exeter, UK; Center for Humans and Machines, Max-Planck Institute for Human Development, Berlin, Germany.
| | - Sydney Levine
- Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; Department of Psychology, Harvard University, Cambridge, MA, USA.
| | - Michael Anderson
- Department of Computer Science, University of Hartford, West Hartford, CT, USA
| | | | - Vincent Conitzer
- Department of Computer Science, Duke University, Durham, NC, USA; Department of Economics, Duke University, Durham, NC, USA; Department of Philosophy, Duke University, Durham, NC, USA; Institute for Ethics in AI, University of Oxford, Oxford, UK
| | - M J Crockett
- Department of Psychology, Yale University, New Haven, CT, USA
| | | | | | - Alison Gopnik
- Department of Psychology, University of California, Berkeley, CA, USA
| | - Julian C Jamison
- Department of Economics, University of Exeter, Exeter, UK; Global Priorities Institute, Oxford University, Oxford, UK
| | - Tae Wan Kim
- Ethics Group, Tepper School of Business, Carnegie Mellon University, Pittsburgh, PA, USA
| | - S Matthew Liao
- Center for Bioethics, New York University, New York, NY, USA
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA, USA; Steele Institute for Health Innovation, Geisinger Health System, Danville, PA, USA; Geisinger Commonwealth School of Medicine, Scranton, PA, USA
| | - John Mikhail
- Georgetown University Law Center, Washington, DC, USA
| | - Kweku Opoku-Agyemang
- International Growth Centre, London School of Economics, London, UK; Machine Learning X Doing, Toronto, ON, Canada; Development Economics X, Toronto, ON, Canada
| | - Jana Schaich Borg
- Social Science Research Institute, Duke University, Durham, NC, USA; Duke Institute for Brain Sciences, Duke University, Durham, NC, USA
| | - Juliana Schroeder
- Haas School of Business, University of California, Berkeley, CA, USA
| | - Walter Sinnott-Armstrong
- Department of Philosophy, Duke University, Durham, NC, USA; Duke Institute for Brain Sciences, Duke University, Durham, NC, USA; Kenan Institute for Ethics, Duke University, Durham, NC, USA
| | - Marija Slavkovik
- Department of Information Science and Media Studies, University of Bergen, Bergen, Norway
| | - Josh B Tenenbaum
- Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, USA; Center for Brains, Minds, and Machines, MIT, Cambridge, MA, USA
| |
Collapse
|
15
|
Spector-Bagdady K, Lynch HF, Bierer BE, Gelinas L, Hull SC, Magnus D, Meyer MN, Sharp RR, Sugarman J, Wilfond BS, Yearby R, Mohapatra S. Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies. Hastings Cent Rep 2022; 52:51-58. [PMID: 34908169 PMCID: PMC9414770 DOI: 10.1002/hast.1297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Covid-19 raised many novel ethical issues including regarding the allocation of opportunities to participate in clinical trials during a public health emergency. In this article, we explore how hospitals that have a scarcity of trial opportunities, either overall or in a specific trial, can equitably allocate those opportunities in the context of an urgent medical need with limited therapeutic interventions. We assess the three main approaches to allocating trial opportunities discussed in the literature: patient choice, physician referral, and randomization/lottery. As, we argue, none of the three typical approaches are ethically ideal for allocating trial opportunities in the pandemic context, many hospitals have instead implemented hybrid solutions. We offer practical guidance to support those continuing to face these challenges, and we analyze options for the future.
Collapse
Affiliation(s)
- Kayte Spector-Bagdady
- Associate Director of the Center for Bioethics & Social Sciences in Medicine and Assistant Professor of Obstetrics and Gynecology at the University of Michigan Medical School
| | - Holly Fernandez Lynch
- John Russell Dickson, MD Presidential Assistant Professor of Medical Ethics and Assistant Professor of Law at the University of Pennsylvania
| | - Barbara E. Bierer
- Professor of Medicine at Harvard Medical School and the Brigham and Women’s Hospital
| | - Luke Gelinas
- IRB Chair at Advarra and a Senior Advisor for the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard
| | - Sara Chandros Hull
- Director of the NHGRI Bioethics Core and member of the Department of Bioethics faculty at the National Institutes of Health
| | - David Magnus
- Thomas A. Raffin Professor of Medicine and Biomedical Ethics and Professor of Pediatrics at Stanford University
| | - Michelle N. Meyer
- Assistant professor and the associate director of research ethics in the Center for Translational Bioethics and Health Care Policy at Geisinger Health System
| | | | - Jeremy Sugarman
- Harvey M. Meyerhoff Professor of Bioethics and Medicine and deputy director for medicine of the Berman Institute of Bioethics at the Johns Hopkins University
| | - Benjamin S. Wilfond
- Professor in the Department of Pediatrics, University of Washington School of Medicine and investigator at the Treuman Katz Center for Pediatric Bioethics, Seattle Children’s Research Institute
| | - Ruqaiijah Yearby
- Full professor and member of the Center for Health Law Studies at Saint Louis University School of Law and co-founder and Executive Director of Saint Louis University’s Institute for Healing Justice and Equity
| | - Seema Mohapatra
- Murray Visiting Professor of Law at SMU Dedman School of Law
| |
Collapse
|
16
|
Becker J, Burik CAP, Goldman G, Wang N, Jayashankar H, Bennett M, Belsky DW, Karlsson Linnér R, Ahlskog R, Kleinman A, Hinds DA, Caspi A, Corcoran DL, Moffitt TE, Poulton R, Sugden K, Williams BS, Harris KM, Steptoe A, Ajnakina O, Milani L, Esko T, Iacono WG, McGue M, Magnusson PKE, Mallard TT, Harden KP, Tucker-Drob EM, Herd P, Freese J, Young A, Beauchamp JP, Koellinger PD, Oskarsson S, Johannesson M, Visscher PM, Meyer MN, Laibson D, Cesarini D, Benjamin DJ, Turley P, Okbay A. Resource profile and user guide of the Polygenic Index Repository. Nat Hum Behav 2021; 5:1744-1758. [PMID: 34140656 PMCID: PMC8678380 DOI: 10.1038/s41562-021-01119-3] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2020] [Accepted: 04/16/2021] [Indexed: 02/05/2023]
Abstract
Polygenic indexes (PGIs) are DNA-based predictors. Their value for research in many scientific disciplines is growing rapidly. As a resource for researchers, we used a consistent methodology to construct PGIs for 47 phenotypes in 11 datasets. To maximize the PGIs' prediction accuracies, we constructed them using genome-wide association studies-some not previously published-from multiple data sources, including 23andMe and UK Biobank. We present a theoretical framework to help interpret analyses involving PGIs. A key insight is that a PGI can be understood as an unbiased but noisy measure of a latent variable we call the 'additive SNP factor'. Regressions in which the true regressor is this factor but the PGI is used as its proxy therefore suffer from errors-in-variables bias. We derive an estimator that corrects for the bias, illustrate the correction, and make a Python tool for implementing it publicly available.
Collapse
Affiliation(s)
- Joel Becker
- Department of Economics, New York University, New York, NY, USA
| | - Casper A P Burik
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - Grant Goldman
- National Bureau of Economic Research, Cambridge, MA, USA
| | - Nancy Wang
- National Bureau of Economic Research, Cambridge, MA, USA
| | | | | | - Daniel W Belsky
- Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA
- Robert N. Butler Columbia Aging Center, Columbia University, New York, NY, USA
| | - Richard Karlsson Linnér
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - Rafael Ahlskog
- Department of Government, Uppsala University, Uppsala, Sweden
| | | | | | - Avshalom Caspi
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
- Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
- Center for Genomic and Computational Biology, Duke University, Durham, NC, USA
- Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
| | - David L Corcoran
- Center for Genomic and Computational Biology, Duke University, Durham, NC, USA
| | - Terrie E Moffitt
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
- Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
- Center for Genomic and Computational Biology, Duke University, Durham, NC, USA
- Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
| | - Richie Poulton
- Dunedin Multidisciplinary Health and Development Research Unit, University of Otago, Dunedin, New Zealand
| | - Karen Sugden
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
| | | | - Kathleen Mullan Harris
- Department of Sociology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Andrew Steptoe
- Department of Behavioural Science and Health, University College London, London, UK
| | - Olesya Ajnakina
- Department of Behavioural Science and Health, University College London, London, UK
- Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK
| | - Lili Milani
- Institute of Genomics, University of Tartu, Tartu, Estonia
| | - Tõnu Esko
- Institute of Genomics, University of Tartu, Tartu, Estonia
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - William G Iacono
- Department of Psychology, University of Minnesota, Minneapolis, MN, USA
| | - Matt McGue
- Department of Psychology, University of Minnesota, Minneapolis, MN, USA
| | - Patrik K E Magnusson
- Swedish Twin Registry, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Travis T Mallard
- Department of Psychology, The University of Texas at Austin, Austin, TX, USA
| | - K Paige Harden
- Department of Psychology, The University of Texas at Austin, Austin, TX, USA
- Population Research Center, The University of Texas at Austin, Austin, TX, USA
| | - Elliot M Tucker-Drob
- Department of Psychology, The University of Texas at Austin, Austin, TX, USA
- Population Research Center, The University of Texas at Austin, Austin, TX, USA
| | - Pamela Herd
- McCourt School of Public Policy, Georgetown University, Washington, DC, USA
| | - Jeremy Freese
- Department of Sociology, Stanford University, Stanford, CA, USA
| | - Alexander Young
- UCLA Anderson School of Management, Los Angeles, CA, USA
- Human Genetics Department, UCLA David Geffen School of Medicine, Los Angeles, CA, USA
| | - Jonathan P Beauchamp
- Interdisciplinary Center for Economic Science and Department of Economics, George Mason University, Fairfax, VA, USA
| | - Philipp D Koellinger
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
- Robert M. La Follette School of Public Affairs, University of Wisconsin-Madison, Madison, WI, USA
| | - Sven Oskarsson
- Department of Government, Uppsala University, Uppsala, Sweden
| | - Magnus Johannesson
- Department of Economics, Stockholm School of Economics, Stockholm, Sweden
| | - Peter M Visscher
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA, USA
| | - David Laibson
- National Bureau of Economic Research, Cambridge, MA, USA
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - David Cesarini
- Department of Economics, New York University, New York, NY, USA.
- National Bureau of Economic Research, Cambridge, MA, USA.
| | - Daniel J Benjamin
- National Bureau of Economic Research, Cambridge, MA, USA.
- UCLA Anderson School of Management, Los Angeles, CA, USA.
- Human Genetics Department, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
| | - Patrick Turley
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA.
- Department of Economics, University of Southern California, Los Angeles, CA, USA.
| | - Aysu Okbay
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
| |
Collapse
|
17
|
Buchanan AH, Manickam K, Meyer MN, Wagner JK, Hallquist MLG, Williams JL, Rahm AK, Williams MS, Chen ZME, Shah CK, Garg TK, Lazzeri AL, Schwartz MLB, Lindbuchler DAM, Fan AL, Leeming R, Servano PO, Smith AL, Vogel VG, Abul-Husn NS, Dewey FE, Lebo MS, Mason-Suares HM, Ritchie MD, Davis FD, Carey DJ, Feinberg DT, Faucett WA, Ledbetter DH, Murray MF. Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants. Genet Med 2021; 23:2470. [PMID: 34646007 PMCID: PMC9119243 DOI: 10.1038/s41436-021-01304-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- Adam H Buchanan
- Geisinger Health System, Danville, PA, USA. .,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA.
| | - Kandamurugu Manickam
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Michelle N Meyer
- Geisinger Health System, Danville, PA, USA.,Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA, USA
| | - Jennifer K Wagner
- Geisinger Health System, Danville, PA, USA.,Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA, USA
| | - Miranda L G Hallquist
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Janet L Williams
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Alanna Kulchak Rahm
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Marc S Williams
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Zong-Ming E Chen
- Geisinger Health System, Danville, PA, USA.,Laboratory Medicine, Geisinger Health System, Danville, PA, USA
| | - Chaitali K Shah
- Geisinger Health System, Danville, PA, USA.,Radiology, Geisinger Health System, Danville, PA, USA
| | - Tullika K Garg
- Geisinger Health System, Danville, PA, USA.,Department of Urology, Geisinger Health System, Danville, PA, USA
| | - Amanda L Lazzeri
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Marci L B Schwartz
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - D' Andra M Lindbuchler
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Audrey L Fan
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Rosemary Leeming
- Geisinger Health System, Danville, PA, USA.,General Surgery, Geisinger Health System, Danville, PA, USA
| | - Pedro O Servano
- Geisinger Health System, Danville, PA, USA.,Family Medicine, Geisinger Health System, Danville, PA, USA
| | - Ashlee L Smith
- Geisinger Health System, Danville, PA, USA.,Women's Health, Geisinger Health System, Danville, PA, USA
| | - Victor G Vogel
- Geisinger Health System, Danville, PA, USA.,Hematology & Oncology, Geisinger Health System, Danville, PA, USA
| | | | | | - Matthew S Lebo
- Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine, Cambridge, MA, USA
| | - Heather M Mason-Suares
- Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine, Cambridge, MA, USA
| | - Marylyn D Ritchie
- Geisinger Health System, Danville, PA, USA.,Biomedical and Translational Informatics, Geisinger Health System, Danville, PA, USA
| | - F Daniel Davis
- Geisinger Health System, Danville, PA, USA.,Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA, USA
| | - David J Carey
- Geisinger Health System, Danville, PA, USA.,Department of Molecular and Functional Genomics, Geisinger Health System, Danville, PA, USA
| | - David T Feinberg
- Geisinger Health System, Danville, PA, USA.,Office of the Chief Executive Officer, Geisinger Health System, Danville, PA, USA
| | - W Andrew Faucett
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - David H Ledbetter
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Michael F Murray
- Geisinger Health System, Danville, PA, USA.,Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA
| |
Collapse
|
18
|
Turley P, Meyer MN, Wang N, Cesarini D, Hammonds E, Martin AR, Neale BM, Rehm HL, Wilkins-Haug L, Benjamin DJ, Hyman S, Laibson D, Visscher PM. Problems With Using Polygenic Scores to Select Embryos. Obstet Gynecol Surv 2021. [DOI: 10.1097/ogx.0000000000000972] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Abstract
In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
Collapse
Affiliation(s)
- Mia Lussier
- Center for Pharmacy Innovation and Outcomes, Geisinger, Forty Fort, PA, USA
| | | | - Eric Wright
- Center for Pharmacy Innovation and Outcomes, Geisinger, Forty Fort, PA, USA
| |
Collapse
|
20
|
Santos HC, Goren A, Chabris CF, Meyer MN. Effect of Targeted Behavioral Science Messages on COVID-19 Vaccination Registration Among Employees of a Large Health System: A Randomized Trial. JAMA Netw Open 2021; 4:e2118702. [PMID: 34319359 PMCID: PMC8319759 DOI: 10.1001/jamanetworkopen.2021.18702] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
This randomized trial evaluates whether individually addressed emails designed with behaviorally informed features increase COVID-19 vaccination rates.
Collapse
Affiliation(s)
- Henri C. Santos
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, Pennsylvania
| | - Amir Goren
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, Pennsylvania
| | - Christopher F. Chabris
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, Pennsylvania
- Autism and Developmental Medicine Institute, Geisinger Health System, Lewisburg, Pennsylvania
| | - Michelle N. Meyer
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, Pennsylvania
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, Pennsylvania
| |
Collapse
|
21
|
Turley P, Meyer MN, Wang N, Cesarini D, Hammonds E, Martin AR, Neale BM, Rehm HL, Wilkins-Haug L, Benjamin DJ, Hyman S, Laibson D, Visscher PM. Problems with Using Polygenic Scores to Select Embryos. N Engl J Med 2021; 385:78-86. [PMID: 34192436 PMCID: PMC8387884 DOI: 10.1056/nejmsr2105065] [Citation(s) in RCA: 83] [Impact Index Per Article: 27.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Companies have recently begun to sell a new service to patients considering in vitro fertilization: embryo selection based on polygenic scores (ESPS). These scores represent individualized predictions of health and other outcomes derived from genomewide association studies in adults to partially predict these outcomes. This article includes a discussion of many factors that lower the predictive power of polygenic scores in the context of embryo selection and quantifies these effects for a variety of clinical and nonclinical traits. Also discussed are potential unintended consequences of ESPS (including selecting for adverse traits, altering population demographics, exacerbating inequalities in society, and devaluing certain traits). Recommendations for the responsible communication about ESPS by practitioners are provided, and a call for a society-wide conversation about this technology is made. (Funded by the National Institute on Aging and others.).
Collapse
Affiliation(s)
- Patrick Turley
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Michelle N Meyer
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Nancy Wang
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - David Cesarini
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Evelynn Hammonds
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Alicia R Martin
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Benjamin M Neale
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Heidi L Rehm
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Louise Wilkins-Haug
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Daniel J Benjamin
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Steven Hyman
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - David Laibson
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| | - Peter M Visscher
- From the University of Southern California (P.T.) and the University of California, Los Angeles (D.J.B.) - both in Los Angeles; Geisinger Health System, Danville, PA (M.N.M.); the National Bureau of Economic Research (N.W., D.C., D.J.B., D.L.), Harvard University (E.H., S.H., D.L.), and the Broad Institute of Harvard and MIT (A.R.M., B.M.N., H.L.R., S.H.) - all in Cambridge, MA; Massachusetts General Hospital (A.R.M., B.M.N., H.L.R.), Harvard Medical School (A.R.M., B.M.N., H.L.R., L.W.-H.), and Brigham and Women's Hospital (L.W.-H.) - all in Boston; New York University, New York (D.C.); and the University of Queensland, Brisbane, Australia (P.M.V.)
| |
Collapse
|
22
|
Wagner JK, Meyer MN. Genomic medicine and the "loss of chance" medical malpractice doctrine. HGG Adv 2021; 2. [PMID: 34250511 PMCID: PMC8270012 DOI: 10.1016/j.xhgg.2021.100032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
As genomic medicine expands, interest in how medical malpractice law will apply to such questions as whether and when to return new or updated genomic results has grown. Given that access to some genomic results (such as those pertaining to minors or those for which scientific interpretations are unsettled) is delayed for years, the “loss of chance” (LOC) doctrine is of particular potential relevance. Yet it has received relatively little attention among scholars of law and genomics. We performed legal research to determine the status of this malpractice doctrine across the United States and consider its potential applicability to genomic medicine. We further examined known genomic medicine malpractices to assess whether this doctrine had yet been invoked in that context. We identified a trend toward adoption of the LOC doctrine, finding 29 states (58%) have adopted, 15 states (30%) have rejected, and six states (12%) have deferred or not yet addressed the doctrine. Attempts to invoke or apply the doctrine in the known genomic medical malpractice cases were also found. While our findings do not provide cause for substantial concern, the availability of the LOC medical malpractice doctrine is a potentially important factor to consider when making programmatic decisions for genomic medicine. Future research examining whether liability risks posed by this doctrine prompt defensive medicine practices would be useful.
Collapse
Affiliation(s)
- Jennifer K Wagner
- Center for Translational Bioethics and Health Care Policy, Geisinger, 100 N. Academy Ave., MC 30-42, Danville, PA 17822, USA
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger, 100 N. Academy Ave., MC 30-42, Danville, PA 17822, USA.,Steele Institute for Health Innovation, Geisinger, 100 N. Academy Ave, Danville, PA 17822, USA
| |
Collapse
|
23
|
Meyer MN, Gelinas L, Bierer BE, Hull SC, Joffe S, Magnus D, Mohapatra S, Sharp RR, Spector-Bagdady K, Sugarman J, Wilfond BS, Lynch HF. An ethics framework for consolidating and prioritizing COVID-19 clinical trials. Clin Trials 2021; 18:226-233. [PMID: 33530721 PMCID: PMC8009845 DOI: 10.1177/1740774520988669] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Given the dearth of established safe and effective interventions to respond to COVID-19, there is an urgent ethical imperative to conduct meaningful clinical research. The good news is that interventions to be tested are not in short supply. Unfortunately, the human and material resources needed to conduct these trials are finite. It is essential that trials be robust and meet enrollment targets and that lower-quality studies not be permitted to displace higher-quality studies, delaying answers to critical questions. Yet, with few exceptions, existing research review bodies and processes are not designed to ensure these conditions are satisfied. To meet this challenge, we offer guidance for research institutions about how to ethically consolidate and prioritize COVID-19 clinical trials, while recognizing that consolidation and prioritization should also take place upstream (among manufacturers and funders) and at a higher level (e.g. nationally). In our proposed three-stage process, trials must first meet threshold criteria. Those that do are evaluated in a second stage to determine whether the institution has sufficient capacity to support all proposed trials. If it does not, the third stage entails evaluating studies against two additional sets of comparative prioritization criteria: those specific to the study and those that aim to advance diversification of an institution's research portfolio. To implement these criteria fairly, we propose that research institutions form COVID-19 research prioritization committees. We briefly discuss some important attributes of these committees, drawing on the authors' experiences at our respective institutions. Although we focus on clinical trials of COVID-19 therapeutics, our guidance should prove useful for other kinds of COVID-19 research, as well as non-pandemic research, which can raise similar challenges due to the scarcity of research resources.
Collapse
Affiliation(s)
- Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy and The Steele Institute for Health Innovation, Geisinger Health System, Danville, PA, USA
| | | | - Barbara E Bierer
- Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
| | - Sara Chandros Hull
- Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD, USA
| | - Steven Joffe
- Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA
| | - David Magnus
- Center for Biomedical Ethics, Stanford University, Stanford, CA, USA
| | - Seema Mohapatra
- Indiana University Robert H. McKinney School of Law, Indiana University, Indianapolis, IN, USA
| | - Richard R Sharp
- Biomedical Ethics Program, Division of Health Care Policy Research, Mayo Clinic, Rochester, MN, USA
| | - Kayte Spector-Bagdady
- Center for Bioethics and Social Sciences in Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Jeremy Sugarman
- Berman Institute of Bioethics and Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
| | - Benjamin S Wilfond
- Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital and Research Institute, Seattle, WA, USA
| | - Holly Fernandez Lynch
- Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
24
|
Mozersky J, Meyer MN, Rahm AK, O'Dell SM, Buchanan A. Balancing External Validity and Concern for Psychosocial Harms in Translational Genetic Research. Ethics Hum Res 2021; 43:43-48. [PMID: 33683017 DOI: 10.1002/eahr.500086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Jessica Mozersky
- Assistant professor in the Bioethics Research Center and a Faculty Scholar in the Institute of Public Health at Washington University School of Medicine
| | - Michelle N Meyer
- Assistant professor and associate director of research ethics at the Center for Translational Bioethics & Health Care Policy, a faculty codirector of the Behavioral Insights Team at the Steele Institute for Healthcare Innovation, and an assistant professor of bioethics at the Geisinger Commonwealth School of Medicine
| | | | - Sean M O'Dell
- Associate in the Department of Psychiatry and Behavioral Health and an assistant professor of clinical research in the Department of Population Health Sciences at Geisinger
| | - Adam Buchanan
- Associate professor and the director of the Genomic Medicine Institute at Geisinger
| |
Collapse
|
25
|
Abstract
This survey study queried employees of a health care system before COVID-19 vaccine distribution to assess their intentions to receive a vaccine and to understand their reasons for hesitancy to do so.
Collapse
Affiliation(s)
- Michelle N. Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, Pennsylvania
- Steele Institute for Health Innovation, Geisinger Health System, Danville, Pennsylvania
- Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania
| | - Tamara Gjorgjieva
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, Pennsylvania
| | - Daniel Rosica
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, Pennsylvania
| |
Collapse
|
26
|
Shermohammed M, Goren A, Lanyado A, Yesharim R, Wolk DM, Doyle J, Meyer MN, Chabris CF. Informing patients that they are at high risk for serious complications of viral infection increases vaccination rates. medRxiv 2021:2021.02.20.21252015. [PMID: 33655258 PMCID: PMC7924279 DOI: 10.1101/2021.02.20.21252015] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
For many vaccine-preventable diseases like influenza, vaccination rates are lower than optimal to achieve community protection. Those at high risk for infection and serious complications are especially advised to be vaccinated to protect themselves. Using influenza as a model, we studied one method of increasing vaccine uptake: informing high-risk patients, identified by a machine learning model, about their risk status. Patients (N=39,717) were evenly randomized to (1) a control condition (exposure only to standard direct mail or patient portal vaccine promotion efforts) or to be told via direct mail, patient portal, and/or SMS that they were (2) at high risk for influenza and its complications if not vaccinated; (3) at high risk according to a review of their medical records; or (4) at high risk according to a computer algorithm analysis of their medical records. Patients in the three treatment conditions were 5.7% more likely to get vaccinated during the 112 days post-intervention (p < .001), and did so 1.4 days earlier (p < .001), on average, than those in the control group. There were no significant differences among risk messages, suggesting that patients are neither especially averse to nor uniquely appreciative of learning their records had been reviewed or that computer algorithms were involved. Similar approaches should be considered for COVID-19 vaccination campaigns.
Collapse
Affiliation(s)
- Maheen Shermohammed
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA 17822, USA
| | - Amir Goren
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA 17822, USA
| | | | | | - Donna M. Wolk
- Department of Laboratory Medicine, Diagnostic Medicine Institute, Geisinger Health System, Danville, PA, USA
| | - Joseph Doyle
- Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA, USA
- National Bureau of Economic Research, Cambridge, MA, USA
| | - Michelle N. Meyer
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA 17822, USA
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA 17822, USA
| | - Christopher F. Chabris
- Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger Health System, Danville, PA 17822, USA
- Autism and Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA 17837, USA
| |
Collapse
|
27
|
Guerrini CJ, Sherkow JS, Meyer MN, Zettler PJ. Transparency is key to ethical vaccine research-Response. Science 2020; 370:1423. [PMID: 33335057 DOI: 10.1126/science.abf4883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
- Christi J Guerrini
- Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX 77030, USA.
| | - Jacob S Sherkow
- College of Law, University of Illinois at Urbana-Champaign, Champaign, IL 61820, USA.,Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.,Center for Advanced Studies in Biomedical Innovation Law, University of Copenhagen Faculty of Law, Copenhagen, Denmark
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy and Steele Institute for Health Innovation, Geisinger Health System, Danville, PA 17822, USA.,Geisinger Commonwealth School of Medicine, Scranton, PA 18510, USA
| | - Patricia J Zettler
- Moritz College of Law, The James Comprehensive Cancer Center and Drug Enforcement and Policy Center, Ohio State University, Columbus, OH 43210, USA
| |
Collapse
|
28
|
Abstract
DIY COVID-19 vaccines raise legal and ethical questions
Collapse
Affiliation(s)
- Christi J Guerrini
- Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
| | - Jacob S Sherkow
- College of Law, University of Illinois at Urbana-Champaign, Champaign, IL, USA.
- Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA
- Center for Advanced Studies in Biomedical Innovation Law, University of Copenhagen Faculty of Law, Copenhagen, Denmark
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy and Steele Institute for Health Innovation, Geisinger Health System, Danville, PA, USA.
- Geisinger Commonwealth School of Medicine, Scranton, PA, USA
| | - Patricia J Zettler
- Moritz College of Law, The James Comprehensive Cancer Center and Drug Enforcement and Policy Center, Ohio State University, Columbus, OH, USA.
| |
Collapse
|
29
|
Affiliation(s)
- James Brian Byrd
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor (J.B.B.)
| | - Natalie Bello
- Department of Medicine, Columbia University Irving Medical Center, New York, NY (N.B.)
| | - Michelle N. Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA (M.N.M.)
| |
Collapse
|
30
|
Savatt JM, Wagner JK, Joffe S, Rahm AK, Williams MS, Bradbury AR, Davis FD, Hergenrather J, Hu Y, Kelly MA, Kirchner HL, Meyer MN, Mozersky J, O'Dell SM, Pervola J, Seeley A, Sturm AC, Buchanan AH. Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents. BMC Pediatr 2020; 20:222. [PMID: 32414353 PMCID: PMC7227212 DOI: 10.1186/s12887-020-02070-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Accepted: 04/06/2020] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND Exome and genome sequencing are routinely used in clinical care and research. These technologies allow for the detection of pathogenic/likely pathogenic variants in clinically actionable genes. However, fueled in part by a lack of empirical evidence, controversy surrounds the provision of genetic results for adult-onset conditions to minors and their parents. We have designed a mixed-methods, longitudinal cohort study to collect empirical evidence to advance this debate. METHODS Pediatric participants in the Geisinger MyCode® Community Health Initiative with available exome sequence data will have their variant files assessed for pathogenic/likely pathogenic variants in 60 genes designated as actionable by MyCode. Eight of these genes are associated with adult-onset conditions (Hereditary Breast and Ovarian Cancer Syndrome (HBOC), Lynch syndrome, MUTYH-associated polyposis, HFE-Associated Hereditary Hemochromatosis), while the remaining genes have pediatric onset. Prior to clinical confirmation of results, pediatric MyCode participants and their parents/legal guardians will be categorized into three study groups: 1) those with an apparent pathogenic/likely pathogenic variant in a gene associated with adult-onset disease, 2) those with an apparent pathogenic/likely pathogenic variant in a gene associated with pediatric-onset disease or with risk reduction interventions that begin in childhood, and 3) those with no apparent genomic result who are sex- and age-matched to Groups 1 and 2. Validated and published quantitative measures, semi-structured interviews, and a review of electronic health record data conducted over a 12-month period following disclosure of results will allow for comparison of psychosocial and behavioral outcomes among parents of minors (ages 0-17) and adolescents (ages 11-17) in each group. DISCUSSION These data will provide guidance about the risks and benefits of informing minors and their family members about clinically actionable, adult-onset genetic conditions and, in turn, help to ensure these patients receive care that promotes physical and psychosocial health. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT03832985. Registered 6 February 2019.
Collapse
Affiliation(s)
| | - Jennifer K Wagner
- Center for Translational Bioethics and Health Care Policy, Geisinger, Danville, PA, USA
| | - Steven Joffe
- Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
| | | | | | - Angela R Bradbury
- Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, USA
- Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA, USA
| | - F Daniel Davis
- Center for Translational Bioethics and Health Care Policy, Geisinger, Danville, PA, USA
| | - Julie Hergenrather
- Department of Psychiatry and Behavioral Health, Geisinger, Danville, PA, USA
| | - Yirui Hu
- Department of Population Health Sciences, Geisinger, Danville, PA, USA
| | | | - H Lester Kirchner
- Department of Population Health Sciences, Geisinger, Danville, PA, USA
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger, Danville, PA, USA
| | - Jessica Mozersky
- Bioethics Research Center, Washington University School of Medicine in St. Louis, St. Louis, MO, USA
| | - Sean M O'Dell
- Department of Psychiatry and Behavioral Health, Geisinger, Danville, PA, USA
- Department of Population Health Sciences, Geisinger, Danville, PA, USA
| | - Josie Pervola
- Genomic Medicine Institute, Geisinger, Danville, PA, USA
| | - Andrea Seeley
- Department of Pediatrics, Geisinger, Danville, PA, USA
| | - Amy C Sturm
- Genomic Medicine Institute, Geisinger, Danville, PA, USA
| | | |
Collapse
|
31
|
Abstract
Using mobile health (mHealth) research as an extended example, this article provides an overview of when the Common Rule "applies" to a variety of activities, what might be meant when one says that the Common Rule does or does not "apply," the extent to which these different meanings of "apply" matter, and, when the Common Rule does apply (however that term is defined), how it applies.
Collapse
Affiliation(s)
- Michelle N Meyer
- Michelle N. Meyer, Ph.D., J.D., is an Assistant Professor and Associate Director, Research Ethics, in the Center for Translational Bioethics & Health Care Policy at Geisinger Health System, where she is also Faculty Co-Director of the Behavioral Insights Team in the Steele Institute for Health Innovation and an Assistant Professor of Bioethics in the Geisinger Commonwealth School of Medicine
| |
Collapse
|
32
|
Abstract
Compared to clinicians previously surveyed, primary care providers employed in a health system known for clinical genomics were more likely to have ordered or referred a patient for genetic testing, but had only modestly more genetics training and reported similarly low levels of comfort answering patient questions about genetic risk. Most supported population genomic screening, reported willingness to get screened themselves, and judged a hypothetical patient's decision to be screened favorably relative to a similar patient's decision to decline screening. Stakeholder perceptions of the ethical appropriateness of nudging at-risk patients to discuss testing with counselors were mixed.
Collapse
Affiliation(s)
- Patrick R Heck
- Autism & Developmental Medicine Institute, Geisinger, 120 Hamm Drive, M-C 60-36, Lewisburg, PA 17827, USA; Center for Translational Bioethics and Health Care Policy, Geisinger, Danville, PA 17822, USA. https://twitter.com/P_HECK
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger, Danville, PA 17822, USA; Behavioral Insights Team, Steele Institute for Health Innovation, Geisinger, 100 North Academy Avenue, M-C 30-57, Danville, PA 17822, USA.
| |
Collapse
|
33
|
|
34
|
Meyer MN, Heck PR, Holtzman GS, Anderson SM, Cai W, Watts DJ, Chabris CF. Objecting to experiments that compare two unobjectionable policies or treatments. Proc Natl Acad Sci U S A 2019; 116:10723-10728. [PMID: 31072934 PMCID: PMC6561206 DOI: 10.1073/pnas.1820701116] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Randomized experiments have enormous potential to improve human welfare in many domains, including healthcare, education, finance, and public policy. However, such "A/B tests" are often criticized on ethical grounds even as similar, untested interventions are implemented without objection. We find robust evidence across 16 studies of 5,873 participants from three diverse populations spanning nine domains-from healthcare to autonomous vehicle design to poverty reduction-that people frequently rate A/B tests designed to establish the comparative effectiveness of two policies or treatments as inappropriate even when universally implementing either A or B, untested, is seen as appropriate. This "A/B effect" is as strong among those with higher educational attainment and science literacy and among relevant professionals. It persists even when there is no reason to prefer A to B and even when recipients are treated unequally and randomly in all conditions (A, B, and A/B). Several remaining explanations for the effect-a belief that consent is required to impose a policy on half of a population but not on the entire population; an aversion to controlled but not to uncontrolled experiments; and a proxy form of the illusion of knowledge (according to which randomized evaluations are unnecessary because experts already do or should know "what works")-appear to contribute to the effect, but none dominates or fully accounts for it. We conclude that rigorously evaluating policies or treatments via pragmatic randomized trials may provoke greater objection than simply implementing those same policies or treatments untested.
Collapse
Affiliation(s)
- Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA 17821;
| | - Patrick R Heck
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA 17821
- Autism and Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA 17837
| | - Geoffrey S Holtzman
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA 17821
- Autism and Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA 17837
| | - Stephen M Anderson
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA 17821
- Autism and Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA 17837
| | - William Cai
- New York City Lab, Microsoft Research, New York, NY 10011
| | - Duncan J Watts
- New York City Lab, Microsoft Research, New York, NY 10011
| | - Christopher F Chabris
- Autism and Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA 17837
- Institute for Advanced Study in Toulouse, 31015 Toulouse, France
| |
Collapse
|
35
|
Karlsson Linnér R, Biroli P, Kong E, Meddens SFW, Wedow R, Fontana MA, Lebreton M, Tino SP, Abdellaoui A, Hammerschlag AR, Nivard MG, Okbay A, Rietveld CA, Timshel PN, Trzaskowski M, Vlaming RD, Zünd CL, Bao Y, Buzdugan L, Caplin AH, Chen CY, Eibich P, Fontanillas P, Gonzalez JR, Joshi PK, Karhunen V, Kleinman A, Levin RZ, Lill CM, Meddens GA, Muntané G, Sanchez-Roige S, Rooij FJV, Taskesen E, Wu Y, Zhang F, Auton A, Boardman JD, Clark DW, Conlin A, Dolan CC, Fischbacher U, Groenen PJF, Harris KM, Hasler G, Hofman A, Ikram MA, Jain S, Karlsson R, Kessler RC, Kooyman M, MacKillop J, Männikkö M, Morcillo-Suarez C, McQueen MB, Schmidt KM, Smart MC, Sutter M, Thurik AR, Uitterlinden AG, White J, Wit HD, Yang J, Bertram L, Boomsma DI, Esko T, Fehr E, Hinds DA, Johannesson M, Kumari M, Laibson D, Magnusson PKE, Meyer MN, Navarro A, Palmer AA, Pers TH, Posthuma D, Schunk D, Stein MB, Svento R, Tiemeier H, Timmers PRHJ, Turley P, Ursano RJ, Wagner GG, Wilson JF, Gratten J, Lee JJ, Cesarini D, Benjamin DJ, Koellinger PD, Beauchamp JP. Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. Nat Genet 2019; 51:245-257. [PMID: 30643258 PMCID: PMC6713272 DOI: 10.1038/s41588-018-0309-3] [Citation(s) in RCA: 331] [Impact Index Per Article: 66.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2018] [Accepted: 11/07/2018] [Indexed: 02/02/2023]
Abstract
Humans vary substantially in their willingness to take risks. In a combined sample of over 1 million individuals, we conducted genome-wide association studies (GWAS) of general risk tolerance, adventurousness, and risky behaviors in the driving, drinking, smoking, and sexual domains. Across all GWAS, we identified hundreds of associated loci, including 99 loci associated with general risk tolerance. We report evidence of substantial shared genetic influences across risk tolerance and the risky behaviors: 46 of the 99 general risk tolerance loci contain a lead SNP for at least one of our other GWAS, and general risk tolerance is genetically correlated ([Formula: see text] ~ 0.25 to 0.50) with a range of risky behaviors. Bioinformatics analyses imply that genes near SNPs associated with general risk tolerance are highly expressed in brain tissues and point to a role for glutamatergic and GABAergic neurotransmission. We found no evidence of enrichment for genes previously hypothesized to relate to risk tolerance.
Collapse
Affiliation(s)
- Richard Karlsson Linnér
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, the Netherlands.
- Erasmus University Rotterdam Institute for Behavior and Biology, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands.
- Department of Economics, VU University Amsterdam, Amsterdam, the Netherlands.
| | - Pietro Biroli
- Department of Economics, University of Zurich, Zurich, Switzerland
| | - Edward Kong
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - S Fleur W Meddens
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, the Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Department of Economics, VU University Amsterdam, Amsterdam, the Netherlands
| | - Robbee Wedow
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA
- Analytic Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Department of Sociology, Harvard University, Cambridge, MA, USA
| | - Mark Alan Fontana
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA
- Department of Healthcare Policy and Research, Weill Cornell Medical College, Cornell University, New York, NY, USA
| | - Maël Lebreton
- Amsterdam School of Economics, University of Amsterdam, Amsterdam, the Netherlands
- Amsterdam Brain and Cognition, University of Amsterdam, Amsterdam, the Netherlands
| | - Stephen P Tino
- Department of Economics, University of Toronto, Toronto, Ontario, Canada
| | - Abdel Abdellaoui
- Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - Anke R Hammerschlag
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, the Netherlands
| | - Michel G Nivard
- Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - Aysu Okbay
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, the Netherlands
- Department of Economics, VU University Amsterdam, Amsterdam, the Netherlands
| | - Cornelius A Rietveld
- Erasmus University Rotterdam Institute for Behavior and Biology, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Pascal N Timshel
- Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
| | - Maciej Trzaskowski
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia
| | - Ronald de Vlaming
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, the Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Department of Economics, VU University Amsterdam, Amsterdam, the Netherlands
| | - Christian L Zünd
- Department of Economics, University of Zurich, Zurich, Switzerland
| | - Yanchun Bao
- Institute for Social and Economic Research, University of Essex, Colchester, UK
| | - Laura Buzdugan
- Seminar for Statistics, Department of Mathematics, ETH Zurich, Zurich, Switzerland
- Department of Economics, University of Zurich, Zurich, Switzerland
| | | | - Chia-Yen Chen
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Analytic Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Psychiatric & Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
| | - Peter Eibich
- Nuffield Department of Population Health, University of Oxford, Oxford, UK
- Socio-Economic Panel Study, DIW Berlin, Berlin, Germany
- Max Planck Institute for Demographic Research, Rostock, Germany
| | | | - Juan R Gonzalez
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain
- Universitat Pompeu Fabra (UPF), Barcelona, Spain
- CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - Peter K Joshi
- Centre for Global Health Research, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland
| | - Ville Karhunen
- Center for Life Course Health Research, University of Oulu, Oulu, Finland
| | | | - Remy Z Levin
- Department of Economics, University of California San Diego, La Jolla, CA, USA
| | - Christina M Lill
- Genetic and Molecular Epidemiology Group, Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Cardiogenetics, University of Lübeck, Lübeck, Germany
| | | | - Gerard Muntané
- Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain
- Research Department, Hospital Universitari Institut Pere Mata, Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain
- Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Reus, Spain
| | | | - Frank J van Rooij
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Erdogan Taskesen
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, the Netherlands
| | - Yang Wu
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia
| | - Futao Zhang
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia
| | - Adam Auton
- Research, 23andMe, Inc., Mountain View, CA, USA
| | - Jason D Boardman
- Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO, USA
- Institute of Behavioral Science, University of Colorado Boulder, Boulder, CO, USA
- Department of Sociology, University of Colorado Boulder, Boulder, CO, USA
| | - David W Clark
- Centre for Global Health Research, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland
| | - Andrew Conlin
- Department of Economics and Finance, Oulu Business School, University of Oulu, Oulu, Finland
| | - Conor C Dolan
- Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - Urs Fischbacher
- Department of Economics, University of Konstanz, Konstanz, Germany
- Thurgau Institute of Economics, Kreuzlingen, Switzerland
| | - Patrick J F Groenen
- Erasmus University Rotterdam Institute for Behavior and Biology, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Department of Econometrics, Erasmus University Rotterdam, Rotterdam, Rotterdam, the Netherlands
| | - Kathleen Mullan Harris
- Department of Sociology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Gregor Hasler
- Unit of Psychiatry Research, University of Fribourg, Fribourg, Switzerland
| | - Albert Hofman
- Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Mohammad A Ikram
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Sonia Jain
- Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA
| | - Robert Karlsson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Ronald C Kessler
- Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
| | | | - James MacKillop
- Peter Boris Centre for Addictions Research, McMaster University/St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada
- Homewood Research Institute, Guelph, Ontario, Canada
| | - Minna Männikkö
- Center for Life Course Health Research, University of Oulu, Oulu, Finland
| | - Carlos Morcillo-Suarez
- Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain
| | - Matthew B McQueen
- Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO, USA
| | - Klaus M Schmidt
- Department of Economics, University of Munich, Munich, Germany
| | - Melissa C Smart
- Institute for Social and Economic Research, University of Essex, Colchester, UK
| | - Matthias Sutter
- Department of Economics, University of Cologne, Cologne, Germany
- Experimental Economics Group, Max Planck Institute for Research into Collective Goods, Bonn, Germany
- Department of Public Finance, University of Innsbruck, Innsbruck, Austria
| | - A Roy Thurik
- Erasmus University Rotterdam Institute for Behavior and Biology, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Montpellier Business School, Montpellier, France
| | - André G Uitterlinden
- Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands
| | - Jon White
- UCL Genetics Institute, Department of Genetics, Evolution and Environment, University College London, London, UK
| | - Harriet de Wit
- Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA
| | - Jian Yang
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia
- Queensland Brain Institute, The University of Queensland, Brisbane, Australia
| | - Lars Bertram
- Genetic and Molecular Epidemiology Group, Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics & Cardiogenetics, University of Lübeck, Lübeck, Germany
- Dept of Psychology, University of Olso, Oslo, Norway
- School of Public Health, Imperial College London, London, UK
| | - Dorret I Boomsma
- Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - Tõnu Esko
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Ernst Fehr
- Department of Economics, University of Zurich, Zurich, Switzerland
| | | | - Magnus Johannesson
- Department of Economics, Stockholm School of Economics, Stockholm, Sweden
| | - Meena Kumari
- Institute for Social and Economic Research, University of Essex, Colchester, UK
| | - David Laibson
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - Patrik K E Magnusson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA, USA
| | - Arcadi Navarro
- Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain
- Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain
| | - Abraham A Palmer
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
- Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA
| | - Tune H Pers
- Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
| | - Danielle Posthuma
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, the Netherlands
- Department of Clinical Genetics, VU Medical Centre, Amsterdam, the Netherlands
| | - Daniel Schunk
- Department of Economics, Johannes Gutenberg University, Mainz, Germany
| | - Murray B Stein
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
- Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA
| | - Rauli Svento
- Department of Economics and Finance, Oulu Business School, University of Oulu, Oulu, Finland
| | - Henning Tiemeier
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Paul R H J Timmers
- Centre for Global Health Research, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland
| | - Patrick Turley
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Analytic Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Behavioral and Health Genomics Center, Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Robert J Ursano
- Department of Psychiatry, Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
| | - Gert G Wagner
- Socio-Economic Panel Study, DIW Berlin, Berlin, Germany
- Max Planck Institute for Human Development, Berlin, Germany
| | - James F Wilson
- Centre for Global Health Research, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, Scotland
| | - Jacob Gratten
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia
- Mater Medical Research Institute, Translational Research Institute, Brisbane, Australia
| | - James J Lee
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, MN, USA
| | - David Cesarini
- Department of Economics, New York University, New York, NY, USA
| | - Daniel J Benjamin
- Behavioral and Health Genomics Center, Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
- Department of Economics, University of Southern California, Los Angeles, CA, USA
- National Bureau of Economic Research, Cambridge, MA, USA
| | - Philipp D Koellinger
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, the Netherlands
- Department of Economics, VU University Amsterdam, Amsterdam, the Netherlands
- German Institute for Economic Research, DIW Berlin, Berlin, Germany
| | | |
Collapse
|
36
|
Williams MS, Buchanan AH, Davis FD, Faucett WA, Hallquist MLG, Leader JB, Martin CL, McCormick CZ, Meyer MN, Murray MF, Rahm AK, Schwartz MLB, Sturm AC, Wagner JK, Williams JL, Willard HF, Ledbetter DH. Patient-Centered Precision Health In A Learning Health Care System: Geisinger's Genomic Medicine Experience. Health Aff (Millwood) 2019; 37:757-764. [PMID: 29733722 DOI: 10.1377/hlthaff.2017.1557] [Citation(s) in RCA: 62] [Impact Index Per Article: 12.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Health care delivery is increasingly influenced by the emerging concepts of precision health and the learning health care system. Although not synonymous with precision health, genomics is a key enabler of individualized care. Delivering patient-centered, genomics-informed care based on individual-level data in the current national landscape of health care delivery is a daunting challenge. Problems to overcome include data generation, analysis, storage, and transfer; knowledge management and representation for patients and providers at the point of care; process management; and outcomes definition, collection, and analysis. Development, testing, and implementation of a genomics-informed program requires multidisciplinary collaboration and building the concepts of precision health into a multilevel implementation framework. Using the principles of a learning health care system provides a promising solution. This article describes the implementation of population-based genomic medicine in an integrated learning health care system-a working example of a precision health program.
Collapse
Affiliation(s)
- Marc S Williams
- Marc S. Williams ( ) is director of the Genomic Medicine Institute, Geisinger, in Danville, Pennsylvania
| | - Adam H Buchanan
- Adam H. Buchanan is an assistant professor at the Genomic Medicine Institute, Geisinger
| | - F Daniel Davis
- F. Daniel Davis is director of the Center for Bioethics and Healthcare Policy, Geisinger
| | - W Andrew Faucett
- W. Andrew Faucett is a professor at the Genomic Medicine Institute, Geisinger
| | - Miranda L G Hallquist
- Miranda L. G. Hallquist is a genetic counselor at the Genomic Medicine Institute, Geisinger
| | - Joseph B Leader
- Joseph B. Leader is director of the Phenomic Analytics and Clinical Data Core, Geisinger
| | - Christa L Martin
- Christa L. Martin is director of the Autism and Developmental Medicine Institute, Geisinger
| | - Cara Z McCormick
- Cara Z. McCormick is a senior assistant at the Genomic Medicine Institute, Geisinger
| | - Michelle N Meyer
- Michelle N. Meyer is associate director for research ethics at the Center for Translational Bioethics and Health Care Policy, Geisinger
| | - Michael F Murray
- Michael F. Murray was a physician in the Genomic Medicine Institute, Geisinger, at the time this work was completed. He is now at the Yale School of Medicine
| | - Alanna K Rahm
- Alanna K. Rahm is an assistant professor at the Genomic Medicine Institute, Geisinger
| | - Marci L B Schwartz
- Marci L. B. Schwartz is a genetic counselor at the Genomic Medicine Institute, Geisinger
| | - Amy C Sturm
- Amy C. Sturm is a professor at the Genomic Medicine Institute, Geisinger
| | - Jennifer K Wagner
- Jennifer K. Wagner is associate director of bioethics research, Center for Translational Bioethics and Health Care Policy, Geisinger
| | - Janet L Williams
- Janet L. Williams is director of research genetic counselors, Genomic Medicine Institute, Geisinger
| | - Huntington F Willard
- Huntington F. Willard is director of the National Precision Health Institute, Geisinger
| | - David H Ledbetter
- David H. Ledbetter is executive vice president and chief scientific officer, Geisinger
| |
Collapse
|
37
|
Lynch HF, Nicholls S, Meyer MN, Taylor HA. Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight. J Empir Res Hum Res Ethics 2018; 14:190-196. [PMID: 30541368 DOI: 10.1177/1556264618812625] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
There are several reasons to believe that Institutional Review Boards (IRBs) and Human Research Protection Programs (HRPPs) contribute to ethical research and the protection of research participants, but there are also important reasons to interrogate this belief. Determining whether IRBs and HRPPs "work" requires empirical evaluation of whether and how well they actually achieve what they were designed to do. In other words, it is critical to examine their outcomes and not only their procedures and structures. In this response to Tsan, we argue that the concept of IRB and HRPP quality entails three dimensions: (1) effectiveness, (2) procedures and structures likely to promote effectiveness, and (3) features unrelated to effectiveness but nonetheless essential, such as efficiency, fairness, and proportionality. Because not all types of quality necessarily guarantee or entail effectiveness, we suggest that broad quality assessments, including such features as regulatory compliance and other procedural measures suggested by Tsan, are unhelpful as the first step in evaluating IRBs and HRPPs. Instead, we must start with outcomes relevant to effectiveness. To do this, we launched the Consortium to Advance Effective Research Ethics Oversight (AEREO), with a mission to define and specify ways to measure relevant outcomes for research ethics oversight, empirically evaluate whether those outcomes are achieved, test new approaches to achieving them, and ultimately, develop and implement empirically-based policy and practice to advance IRB and HRPP effectiveness. We describe several anticipated AEREO projects and call for collaboration between various stakeholders to more meaningfully evaluate IRB and HRPPs.
Collapse
Affiliation(s)
| | | | | | - Holly A Taylor
- 4 Johns Hopkins University Berman Institute of Bioethics, Baltimore, MD, USA
| | -
- The following AEREO Consortium Members endorse this article in their individual capacities and not necessarily on behalf of any institutions of which they are a part: Angela Bain, Barbara E. Bierer, Justin Clapp, Anne K. Clark, Carl Coleman, Whitney Eriksen, Jonathan Green, Sarah Greene, Elisa A. Hurley, Steven Joffe, Susan Kornetsky, Lisa M. Lee, Lindsay McNair, Linda Parreco, Suzanne M. Rivera, Stephen Rosenfeld, Michele Russell-Einhorn, Megan Singleton, David H. Strauss, Emma Tumilty, and Tracy Ziolek. This publication represents the views of the authors and does not reflect the official position or policy of the National Cancer Institute, the National Institutes of Health, or the Department of Health and Human Services
| |
Collapse
|
38
|
Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, Nguyen-Viet TA, Bowers P, Sidorenko J, Karlsson Linnér R, Fontana MA, Kundu T, Lee C, Li H, Li R, Royer R, Timshel PN, Walters RK, Willoughby EA, Yengo L, Alver M, Bao Y, Clark DW, Day FR, Furlotte NA, Joshi PK, Kemper KE, Kleinman A, Langenberg C, Mägi R, Trampush JW, Verma SS, Wu Y, Lam M, Zhao JH, Zheng Z, Boardman JD, Campbell H, Freese J, Harris KM, Hayward C, Herd P, Kumari M, Lencz T, Luan J, Malhotra AK, Metspalu A, Milani L, Ong KK, Perry JRB, Porteous DJ, Ritchie MD, Smart MC, Smith BH, Tung JY, Wareham NJ, Wilson JF, Beauchamp JP, Conley DC, Esko T, Lehrer SF, Magnusson PKE, Oskarsson S, Pers TH, Robinson MR, Thom K, Watson C, Chabris CF, Meyer MN, Laibson DI, Yang J, Johannesson M, Koellinger PD, Turley P, Visscher PM, Benjamin DJ, Cesarini D. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet 2018; 50:1112-1121. [PMID: 30038396 PMCID: PMC6393768 DOI: 10.1038/s41588-018-0147-3] [Citation(s) in RCA: 1186] [Impact Index Per Article: 197.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Accepted: 04/30/2018] [Indexed: 02/06/2023]
Abstract
Here we conducted a large-scale genetic association analysis of educational attainment in a sample of approximately 1.1 million individuals and identify 1,271 independent genome-wide-significant SNPs. For the SNPs taken together, we found evidence of heterogeneous effects across environments. The SNPs implicate genes involved in brain-development processes and neuron-to-neuron communication. In a separate analysis of the X chromosome, we identify 10 independent genome-wide-significant SNPs and estimate a SNP heritability of around 0.3% in both men and women, consistent with partial dosage compensation. A joint (multi-phenotype) analysis of educational attainment and three related cognitive phenotypes generates polygenic scores that explain 11-13% of the variance in educational attainment and 7-10% of the variance in cognitive performance. This prediction accuracy substantially increases the utility of polygenic scores as tools in research.
Collapse
Affiliation(s)
- James J Lee
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, MN, USA
| | - Robbee Wedow
- Department of Sociology, University of Colorado Boulder, Boulder, CO, USA
- Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO, USA
- Institute of Behavioral Science, University of Colorado Boulder, Boulder, CO, USA
| | - Aysu Okbay
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
| | - Edward Kong
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - Omeed Maghzian
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - Meghan Zacher
- Department of Sociology, Harvard University, Cambridge, MA, USA
| | - Tuan Anh Nguyen-Viet
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Peter Bowers
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - Julia Sidorenko
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Richard Karlsson Linnér
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- Institute for Behavior and Biology, Erasmus University Rotterdam, Rotterdam, The Netherlands
| | - Mark Alan Fontana
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
- Center for the Advancement of Value in Musculoskeletal Care, Hospital for Special Surgery, New York, NY, USA
| | - Tushar Kundu
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Chanwook Lee
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - Hui Li
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - Ruoxi Li
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Rebecca Royer
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Pascal N Timshel
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark
- Statens Serum Institut, Department of Epidemiology Research, Copenhagen, Denmark
| | - Raymond K Walters
- Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Emily A Willoughby
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, MN, USA
| | - Loïc Yengo
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
| | - Maris Alver
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Yanchun Bao
- Institute for Social and Economic Research, University of Essex, Colchester, UK
| | - David W Clark
- Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
| | - Felix R Day
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | | | - Peter K Joshi
- Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
- Institute of Social and Preventive Medicine, University Hospital of Lausanne, Lausanne, Switzerland
| | - Kathryn E Kemper
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
| | | | - Claudia Langenberg
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - Reedik Mägi
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Joey W Trampush
- BrainWorkup, LLC, Santa Monica, CA, USA
- Department of Psychiatry and Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - Shefali Setia Verma
- Department of Biomedical and Translational Informatics, Geisinger Health System, Danville, PA, USA
| | - Yang Wu
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
| | - Max Lam
- Institute of Mental Health, Singapore, Singapore
- Genome Institute, Singapore, Singapore
| | - Jing Hua Zhao
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - Zhili Zheng
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
- The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China
| | - Jason D Boardman
- Department of Sociology, University of Colorado Boulder, Boulder, CO, USA
- Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO, USA
- Institute of Behavioral Science, University of Colorado Boulder, Boulder, CO, USA
| | - Harry Campbell
- Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
| | - Jeremy Freese
- Department of Sociology, Stanford University, Stanford, CA, USA
| | - Kathleen Mullan Harris
- Department of Sociology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Caroline Hayward
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
| | - Pamela Herd
- Institute for Social and Economic Research, University of Essex, Colchester, UK
- La Follette School of Public Affairs, University of Wisconsin-Madison, Madison, WI, USA
| | - Meena Kumari
- Institute for Social and Economic Research, University of Essex, Colchester, UK
| | - Todd Lencz
- Departments of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, NY, USA
- Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA
- Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, CA, USA
| | - Jian'an Luan
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - Anil K Malhotra
- Departments of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, NY, USA
- Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA
- Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, CA, USA
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu, Tartu, Estonia
- Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
| | - Lili Milani
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Ken K Ong
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - John R B Perry
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - David J Porteous
- Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
| | - Marylyn D Ritchie
- Department of Biomedical and Translational Informatics, Geisinger Health System, Danville, PA, USA
| | - Melissa C Smart
- Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
| | - Blair H Smith
- Division of Population Health Sciences, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK
- Medical Research Institute, University of Dundee, Dundee, UK
| | | | - Nicholas J Wareham
- MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - James F Wilson
- Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
| | | | - Dalton C Conley
- Department of Sociology, Princeton University, Princeton, NJ, USA
| | - Tõnu Esko
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Steven F Lehrer
- School of Policy Studies, Queen's University, Kingston, Ontario, Canada
- Department of Economics, New York University Shanghai, Pudong, Shanghai, China
- National Bureau of Economic Research, Cambridge, MA, USA
| | - Patrik K E Magnusson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Sven Oskarsson
- Department of Government, Uppsala University, Uppsala, Sweden
| | - Tune H Pers
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark
- Statens Serum Institut, Department of Epidemiology Research, Copenhagen, Denmark
| | - Matthew R Robinson
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
- Department of Computational Biology, University of Lausanne, Lausanne, Switzerland
| | - Kevin Thom
- Department of Economics, New York University, New York, NY, USA
| | - Chelsea Watson
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Christopher F Chabris
- Autism and Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA, USA
| | - Michelle N Meyer
- Center for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA, USA
| | - David I Laibson
- Department of Economics, Harvard University, Cambridge, MA, USA
| | - Jian Yang
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
| | - Magnus Johannesson
- Department of Economics, Stockholm School of Economics, Stockholm, Sweden
| | - Philipp D Koellinger
- Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- Department of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- Institute for Behavior and Biology, Erasmus University Rotterdam, Rotterdam, The Netherlands
| | - Patrick Turley
- Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Peter M Visscher
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia.
| | - Daniel J Benjamin
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA.
- National Bureau of Economic Research, Cambridge, MA, USA.
- Department of Economics, University of Southern California, Los Angeles, CA, USA.
| | - David Cesarini
- National Bureau of Economic Research, Cambridge, MA, USA
- Department of Economics, New York University, New York, NY, USA
- Center for Experimental Social Science, New York University, New York, NY, USA
| |
Collapse
|
39
|
Abstract
This Tutorial provides practical dos and don’ts for sharing research data in ways that are effective, ethical, and compliant with the federal Common Rule. I first consider best practices for prospectively incorporating data-sharing plans into research, discussing what to say—and what not to say—in consent forms and institutional review board applications, tools for data de-identification and how to think about the risks of re-identification, and what to consider when selecting a data repository. Turning to data that have already been collected, I discuss the ethical and regulatory issues raised by sharing data when the consent form either was silent about data sharing or explicitly promised participants that the data would not be shared. Finally, I discuss ethical issues in sharing “public” data.
Collapse
|
40
|
|
41
|
Okbay A, Baselmans BML, Neve JED, Turley P, Nivard MG, Fontana MA, Meddens SFW, Linnér RK, Rietveld CA, Derringer J, Gratten J, Lee JJ, Liu JZ, de Vlaming R, Ahluwalia TS, Buchwald J, Cavadino A, Frazier-Wood AC, Furlotte NA, Garfield V, Geisel MH, Gonzalez JR, Haitjema S, Karlsson R, van der Laan SW, Ladwig KH, Lahti J, van der Lee SJ, Lind PA, Liu T, Matteson L, Mihailov E, Miller MB, Minica CC, Nolte IM, Mook-Kanamori D, van der Most PJ, Oldmeadow C, Qian Y, Raitakari O, Rawal R, Realo A, Rueedi R, Schmidt B, Smith AV, Stergiakouli E, Tanaka T, Taylor K, Thorleifsson G, Wedenoja J, Wellmann J, Westra HJ, Willems SM, Zhao W, Amin N, Bakshi A, Bergmann S, Bjornsdottir G, Boyle PA, Cherney S, Cox SR, Davies G, Davis OSP, Ding J, Direk N, Eibich P, Emeny RT, Fatemifar G, Faul JD, Ferrucci L, Forstner AJ, Gieger C, Gupta R, Harris TB, Harris JM, Holliday EG, Hottenga JJ, Jager PLD, Kaakinen MA, Kajantie E, Karhunen V, Kolcic I, Kumari M, Launer LJ, Franke L, Li-Gao R, Liewald DC, Koini M, Loukola A, Marques-Vidal P, Montgomery GW, Mosing MA, Paternoster L, Pattie A, Petrovic KE, Pulkki-Råback L, Quaye L, Räikkönen K, Rudan I, Scott RJ, Smith JA, Sutin AR, Trzaskowski M, Vinkhuyzen AE, Yu L, Zabaneh D, Attia JR, Bennett DA, Berger K, Bertram L, Boomsma DI, Snieder H, Chang SC, Cucca F, Deary IJ, van Duijn CM, Eriksson JG, Bültmann U, de Geus EJC, Groenen PJF, Gudnason V, Hansen T, Hartman CA, Haworth CMA, Hayward C, Heath AC, Hinds DA, Hyppönen E, Iacono WG, Järvelin MR, Jöckel KH, Kaprio J, Kardia SLR, Keltikangas-Järvinen L, Kraft P, Kubzansky LD, Lehtimäki T, Magnusson PKE, Martin NG, McGue M, Metspalu A, Mills M, de Mutsert R, Oldehinkel AJ, Pasterkamp G, Pedersen NL, Plomin R, Polasek O, Power C, Rich SS, Rosendaal FR, den Ruijter HM, Schlessinger D, Schmidt H, Svento R, Schmidt R, Alizadeh BZ, Sørensen TIA, Spector TD, Starr JM, Stefansson K, Steptoe A, Terracciano A, Thorsteinsdottir U, Thurik AR, Timpson NJ, Tiemeier H, Uitterlinden AG, Vollenweider P, Wagner GG, Weir DR, Yang J, Conley DC, Smith GD, Hofman A, Johannesson M, Laibson DI, Medland SE, Meyer MN, Pickrell JK, Esko T, Krueger RF, Beauchamp JP, Koellinger PD, Benjamin DJ, Bartels M, Cesarini D. Corrigendum: Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat Genet 2016; 48:970. [PMID: 27463399 DOI: 10.1038/ng0816-970c] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
42
|
Okbay A, Baselmans BML, De Neve JE, Turley P, Nivard MG, Fontana MA, Meddens SFW, Linnér RK, Rietveld CA, Derringer J, Gratten J, Lee JJ, Liu JZ, de Vlaming R, Ahluwalia TS, Buchwald J, Cavadino A, Frazier-Wood AC, Furlotte NA, Garfield V, Geisel MH, Gonzalez JR, Haitjema S, Karlsson R, van der Laan SW, Ladwig KH, Lahti J, van der Lee SJ, Lind PA, Liu T, Matteson L, Mihailov E, Miller MB, Minica CC, Nolte IM, Mook-Kanamori D, van der Most PJ, Oldmeadow C, Qian Y, Raitakari O, Rawal R, Realo A, Rueedi R, Schmidt B, Smith AV, Stergiakouli E, Tanaka T, Taylor K, Thorleifsson G, Wedenoja J, Wellmann J, Westra HJ, Willems SM, Zhao W, Amin N, Bakshi A, Bergmann S, Bjornsdottir G, Boyle PA, Cherney S, Cox SR, Davies G, Davis OSP, Ding J, Direk N, Eibich P, Emeny RT, Fatemifar G, Faul JD, Ferrucci L, Forstner AJ, Gieger C, Gupta R, Harris TB, Harris JM, Holliday EG, Hottenga JJ, De Jager PL, Kaakinen MA, Kajantie E, Karhunen V, Kolcic I, Kumari M, Launer LJ, Franke L, Li-Gao R, Liewald DC, Koini M, Loukola A, Marques-Vidal P, Montgomery GW, Mosing MA, Paternoster L, Pattie A, Petrovic KE, Pulkki-Råback L, Quaye L, Räikkönen K, Rudan I, Scott RJ, Smith JA, Sutin AR, Trzaskowski M, Vinkhuyzen AE, Yu L, Zabaneh D, Attia JR, Bennett DA, Berger K, Bertram L, Boomsma DI, Snieder H, Chang SC, Cucca F, Deary IJ, van Duijn CM, Eriksson JG, Bültmann U, de Geus EJC, Groenen PJF, Gudnason V, Hansen T, Hartman CA, Haworth CMA, Hayward C, Heath AC, Hinds DA, Hyppönen E, Iacono WG, Järvelin MR, Jöckel KH, Kaprio J, Kardia SLR, Keltikangas-Järvinen L, Kraft P, Kubzansky LD, Lehtimäki T, Magnusson PKE, Martin NG, McGue M, Metspalu A, Mills M, de Mutsert R, Oldehinkel AJ, Pasterkamp G, Pedersen NL, Plomin R, Polasek O, Power C, Rich SS, Rosendaal FR, den Ruijter HM, Schlessinger D, Schmidt H, Svento R, Schmidt R, Alizadeh BZ, Sørensen TIA, Spector TD, Starr JM, Stefansson K, Steptoe A, Terracciano A, Thorsteinsdottir U, Thurik AR, Timpson NJ, Tiemeier H, Uitterlinden AG, Vollenweider P, Wagner GG, Weir DR, Yang J, Conley DC, Smith GD, Hofman A, Johannesson M, Laibson DI, Medland SE, Meyer MN, Pickrell JK, Esko T, Krueger RF, Beauchamp JP, Koellinger PD, Benjamin DJ, Bartels M, Cesarini D. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat Genet 2016; 48:624-33. [PMID: 27089181 PMCID: PMC4884152 DOI: 10.1038/ng.3552] [Citation(s) in RCA: 561] [Impact Index Per Article: 70.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2015] [Accepted: 03/24/2016] [Indexed: 12/15/2022]
Abstract
Very few genetic variants have been associated with depression and neuroticism, likely because of limitations on sample size in previous studies. Subjective well-being, a phenotype that is genetically correlated with both of these traits, has not yet been studied with genome-wide data. We conducted genome-wide association studies of three phenotypes: subjective well-being (n = 298,420), depressive symptoms (n = 161,460), and neuroticism (n = 170,911). We identify 3 variants associated with subjective well-being, 2 variants associated with depressive symptoms, and 11 variants associated with neuroticism, including 2 inversion polymorphisms. The two loci associated with depressive symptoms replicate in an independent depression sample. Joint analyses that exploit the high genetic correlations between the phenotypes (|ρ^| ≈ 0.8) strengthen the overall credibility of the findings and allow us to identify additional variants. Across our phenotypes, loci regulating expression in central nervous system and adrenal or pancreas tissues are strongly enriched for association.
Collapse
Affiliation(s)
- Aysu Okbay
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, the Netherlands
| | - Bart M L Baselmans
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
- EMGO+ Institute for Health and Care Research, Amsterdam, the Netherlands
| | | | - Patrick Turley
- Department of Economics, Harvard University, Cambridge, Massachusetts, USA
| | - Michel G Nivard
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
| | - Mark Alan Fontana
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA
| | - S Fleur W Meddens
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, the Netherlands
- Department of Complex Trait Genetics, Vrije Universiteit, Center for Neurogenomics and Cognitive Research, Amsterdam, the Netherlands
- Amsterdam Business School, University of Amsterdam, Amsterdam, the Netherlands
| | - Richard Karlsson Linnér
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, the Netherlands
- Department of Complex Trait Genetics, Vrije Universiteit, Center for Neurogenomics and Cognitive Research, Amsterdam, the Netherlands
- Amsterdam Business School, University of Amsterdam, Amsterdam, the Netherlands
| | - Cornelius A Rietveld
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, the Netherlands
| | - Jaime Derringer
- Department of Psychology, University of Illinois, Champaign, Illinois, USA
| | - Jacob Gratten
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
| | - James J Lee
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA
| | - Jimmy Z Liu
- New York Genome Center, New York, New York, USA
| | - Ronald de Vlaming
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, the Netherlands
| | - Tarunveer S Ahluwalia
- COPSAC (Copenhagen Prospective Studies on Asthma in Childhood), Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark
- Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark
- Steno Diabetes Center, Gentofte, Denmark
| | - Jadwiga Buchwald
- Department of Public Health, University of Helsinki, Helsinki, Finland
| | - Alana Cavadino
- Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
- South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
| | - Alexis C Frazier-Wood
- USDA-ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, USA
| | | | - Victoria Garfield
- Department of Epidemiology and Public Health, University College London, London, UK
| | - Marie Henrike Geisel
- Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany
| | - Juan R Gonzalez
- Centre for Research in Environmental Epidemiology, Institute for Global Health, Barcelona, Spain
- Universitat Pompeu Fabra, Barcelona, Spain
- CIBER Epidemiología y Salud Pública, Barcelona, Spain
| | - Saskia Haitjema
- Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Robert Karlsson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Sander W van der Laan
- Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Karl-Heinz Ladwig
- Department of Psychosomatic Medicine and Psychotherapy, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
| | - Jari Lahti
- Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland
- Folkhälsan Research Centre, Helsingfors, Finland
- Helsinki Collegium for Advanced Studies, University of Helsinki, Helsinki, Finland
| | - Sven J van der Lee
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Penelope A Lind
- Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - Tian Liu
- Max Planck Institute for Human Development, Berlin, Germany
- Max Planck Institute for Molecular Genetics, Department of Vertebrate Genomics, Berlin, Germany
| | - Lindsay Matteson
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA
| | | | - Michael B Miller
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA
| | - Camelia C Minica
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
| | - Ilja M Nolte
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Dennis Mook-Kanamori
- Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
- Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands
- BESC, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Peter J van der Most
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Christopher Oldmeadow
- Public Health Stream, Hunter Medical Research Institute, New Lambton, New South Wales, Australia
- Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
| | - Yong Qian
- Laboratory of Genetics, National Institute on Aging, Baltimore, Maryland, USA
| | - Olli Raitakari
- Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland
- Department of Clinical Physiology, Turku University Hospital, Turku, Finland
| | - Rajesh Rawal
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
| | - Anu Realo
- Department of Psychology, University of Tartu, Tartu, Estonia
- Department of Psychology, University of Warwick, Coventry, UK
| | - Rico Rueedi
- Department of Computational Biology, University of Lausanne, Lausanne, Switzerland
- Swiss Institute of Bioinformatics, Lausanne, Switzerland
| | - Börge Schmidt
- Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany
| | - Albert V Smith
- Icelandic Heart Association, Kopavogur, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Evie Stergiakouli
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
| | - Toshiko Tanaka
- National Institute on Aging, US National Institutes of Health, Baltimore, Maryland, USA
| | - Kent Taylor
- Los Angeles Biomedical Research Institute and Department of Pediatrics, Harbor-UCLA, Torrence, California, USA
| | | | - Juho Wedenoja
- Department of Public Health, University of Helsinki, Helsinki, Finland
| | - Juergen Wellmann
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
| | - Harm-Jan Westra
- Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
- Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Sara M Willems
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Wei Zhao
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA
| | - Najaf Amin
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Andrew Bakshi
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
| | | | | | - Patricia A Boyle
- Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | | | - Simon R Cox
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK
- Department of Psychology, University of Edinburgh, Edinburgh, UK
| | - Gail Davies
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK
- Department of Psychology, University of Edinburgh, Edinburgh, UK
| | - Oliver S P Davis
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
| | - Jun Ding
- Laboratory of Genetics, National Institute on Aging, Baltimore, Maryland, USA
| | - Nese Direk
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Peter Eibich
- German Socio-Economic Panel Study, DIW Berlin, Berlin, Germany
- Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
| | - Rebecca T Emeny
- Institute of Epidemiology II, Mental Health Research Unit, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
- Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA
| | - Ghazaleh Fatemifar
- Farr Institute of Health Informatics, University College London, London, UK
| | - Jessica D Faul
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA
| | - Luigi Ferrucci
- National Institute on Aging, US National Institutes of Health, Baltimore, Maryland, USA
| | - Andreas J Forstner
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany
| | - Christian Gieger
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
| | - Richa Gupta
- Department of Public Health, University of Helsinki, Helsinki, Finland
| | - Tamara B Harris
- Laboratory of Epidemiology, Demography, National Institute on Aging, US National Institutes of Health, Bethesda, Maryland, USA
| | - Juliette M Harris
- Department of Twin Research and Genetic Epidemiology, King's College London, London, UK
| | - Elizabeth G Holliday
- Public Health Stream, Hunter Medical Research Institute, New Lambton, New South Wales, Australia
- Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
| | - Jouke-Jan Hottenga
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
- EMGO+ Institute for Health and Care Research, Amsterdam, the Netherlands
| | - Philip L De Jager
- Program in Translational NeuroPsychiatric Genomics, Departments of Neurology and Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA
- Harvard Medical School, Boston, Massachusetts, USA
- Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
| | - Marika A Kaakinen
- Department of Genomics of Common Disease, Imperial College London, London, UK
- Center for Life Course Health Research, University of Oulu and Oulu University Hospital, Oulu, Finland
| | - Eero Kajantie
- Department of Pediatrics, University of Helsinki, Helsinki, Finland
- National Institute for Health and Welfare, Helsinki, Finland
| | - Ville Karhunen
- Center for Life Course Health Research, University of Oulu and Oulu University Hospital, Oulu, Finland
| | - Ivana Kolcic
- Department of Public Health, Faculty of Medicine, University of Split, Split, Croatia
| | - Meena Kumari
- Institute for Social and Economic Research, University of Essex, Wivenhoe Park, UK
| | - Lenore J Launer
- Neuroepidemiology Section, National Institute on Aging, US National Institutes of Health, Bethesda, Maryland, USA
| | - Lude Franke
- Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
| | - Ruifang Li-Gao
- Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
| | | | - Marisa Koini
- Department of Neurology, General Hospital and Medical University Graz, Graz, Austria
| | - Anu Loukola
- Department of Public Health, University of Helsinki, Helsinki, Finland
| | - Pedro Marques-Vidal
- Department of Internal Medicine, Internal Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland
| | - Grant W Montgomery
- Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - Miriam A Mosing
- Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | | | - Alison Pattie
- Department of Psychology, University of Edinburgh, Edinburgh, UK
| | - Katja E Petrovic
- Department of Neurology, General Hospital and Medical University Graz, Graz, Austria
| | - Laura Pulkki-Råback
- Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland
- Helsinki Collegium for Advanced Studies, University of Helsinki, Helsinki, Finland
| | - Lydia Quaye
- Department of Twin Research and Genetic Epidemiology, King's College London, London, UK
| | - Katri Räikkönen
- Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland
| | - Igor Rudan
- Centre for Global Health Research, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
| | - Rodney J Scott
- Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
- Information-Based Medicine Stream, Hunter Medical Research Institute, New Lambton, New South Wales, Australia
| | - Jennifer A Smith
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA
| | - Angelina R Sutin
- National Institute on Aging, US National Institutes of Health, Baltimore, Maryland, USA
- Department of Behavioral Sciences and Social Medicine, Florida State University College of Medicine, Tallahassee, Florida, USA
| | - Maciej Trzaskowski
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
- Department of Public Health, Faculty of Medicine, University of Split, Split, Croatia
| | - Anna E Vinkhuyzen
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
| | - Lei Yu
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Delilah Zabaneh
- Department of Public Health, Faculty of Medicine, University of Split, Split, Croatia
| | - John R Attia
- Public Health Stream, Hunter Medical Research Institute, New Lambton, New South Wales, Australia
- Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
| | - David A Bennett
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Klaus Berger
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
| | - Lars Bertram
- Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institute of Neurogenetics and Institute of Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany
- Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, Imperial College London, London, UK
| | - Dorret I Boomsma
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
- EMGO+ Institute for Health and Care Research, Amsterdam, the Netherlands
- Neuroscience Campus Amsterdam, Amsterdam, the Netherlands
| | - Harold Snieder
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Shun-Chiao Chang
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
| | - Francesco Cucca
- Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche, Cittadella Universitarià di Monserrato, Monserrato, Italy
| | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK
- Department of Psychology, University of Edinburgh, Edinburgh, UK
| | | | - Johan G Eriksson
- Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland
- Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
- Unit of General Practice, University Central Hospital, Helsinki, Finland
| | - Ute Bültmann
- Department of Health Sciences, Community and Occupational Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Eco J C de Geus
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
- EMGO+ Institute for Health and Care Research, Amsterdam, the Netherlands
- Neuroscience Campus Amsterdam, Amsterdam, the Netherlands
| | - Patrick J F Groenen
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, the Netherlands
- Econometric Institute, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Torben Hansen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark
| | - Catharine A Hartman
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | | | - Caroline Hayward
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
| | - Andrew C Heath
- Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA
| | | | - Elina Hyppönen
- South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
- Centre for Population Health Research, School of Health Sciences and Sansom Institute, University of South Australia, Adelaide, South Australia, Australia
- Population, Policy and Practice, UCL Institute of Child Health, London, UK
| | - William G Iacono
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA
| | - Marjo-Riitta Järvelin
- Department of Genomics of Common Disease, Imperial College London, London, UK
- Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK
- Biocenter Oulu, University of Oulu, Oulu, Finland
- Unit of Primary Care, Oulu University Hospital, Oulu, Finland
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany
| | - Jaakko Kaprio
- Department of Public Health, University of Helsinki, Helsinki, Finland
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
- Department for Health, THL (National Institute for Health and Welfare), Helsinki, Finland
| | - Sharon L R Kardia
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA
| | | | - Peter Kraft
- Department of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
| | - Laura D Kubzansky
- Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
| | - Terho Lehtimäki
- Fimlab Laboratories, Tampere, Finland
- Department of Clinical Chemistry, University of Tampere, School of Medicine, Tampere, Finland
| | - Patrik K E Magnusson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Nicholas G Martin
- Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - Matt McGue
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu, Tartu, Estonia
- Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
| | - Melinda Mills
- Department of Sociology, University of Oxford, Oxford, UK
| | - Renée de Mutsert
- Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
| | - Albertine J Oldehinkel
- Econometric Institute, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
| | - Gerard Pasterkamp
- Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands
- Laboratory of Clinical Chemistry and Hematology, Division of Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Nancy L Pedersen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Robert Plomin
- Social, Genetic and Developmental Psychiatry Centre, King's College London, De Crespigny Park, UK
| | - Ozren Polasek
- Department of Public Health, Faculty of Medicine, University of Split, Split, Croatia
| | - Christine Power
- South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
- Population, Policy and Practice, UCL Institute of Child Health, London, UK
| | - Stephen S Rich
- Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA
| | - Frits R Rosendaal
- Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
| | - Hester M den Ruijter
- Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - David Schlessinger
- Laboratory of Genetics, National Institute on Aging, Baltimore, Maryland, USA
| | - Helena Schmidt
- Department of Neurology, General Hospital and Medical University Graz, Graz, Austria
- Research Unit for Genetic Epidemiology, Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, General Hospital and Medical University Graz, Graz, Austria
| | - Rauli Svento
- Department of Economics, Oulu Business School, Oulu, Finland
| | - Reinhold Schmidt
- Department of Neurology, General Hospital and Medical University Graz, Graz, Austria
| | - Behrooz Z Alizadeh
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
- Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Thorkild I A Sørensen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
- Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals, Capital Region, Frederiksberg, Denmark
| | - Tim D Spector
- Department of Twin Research and Genetic Epidemiology, King's College London, London, UK
| | | | | | - Andrew Steptoe
- Department of Epidemiology and Public Health, University College London, London, UK
| | - Antonio Terracciano
- National Institute on Aging, US National Institutes of Health, Baltimore, Maryland, USA
- Department of Behavioral Sciences and Social Medicine, Florida State University College of Medicine, Tallahassee, Florida, USA
| | | | - A Roy Thurik
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, the Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, the Netherlands
- Montpellier Business School, Montpellier, France
- Panteia, Zoetermeer, the Netherlands
| | | | - Henning Tiemeier
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
- Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands
- Department of Child and Adolescent Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands
| | - André G Uitterlinden
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, the Netherlands
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Peter Vollenweider
- Department of Internal Medicine, Internal Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland
| | - Gert G Wagner
- Max Planck Institute for Human Development, Berlin, Germany
- German Socio-Economic Panel Study, DIW Berlin, Berlin, Germany
- School of Economics and Management, Berlin University of Technology, Berlin, Germany
| | - David R Weir
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA
| | - Jian Yang
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
- University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia
| | - Dalton C Conley
- Department of Sociology, Princeton University, Princeton, New Jersey, USA
| | | | - Albert Hofman
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
| | - Magnus Johannesson
- Department of Economics, Stockholm School of Economics, Stockholm, Sweden
| | - David I Laibson
- Department of Economics, Harvard University, Cambridge, Massachusetts, USA
| | - Sarah E Medland
- Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - Michelle N Meyer
- Department of Bioethics, Clarkson University, Schenectady, New York, USA
- Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Joseph K Pickrell
- New York Genome Center, New York, New York, USA
- Department of Biological Sciences, Columbia University, New York, New York, USA
| | - Tõnu Esko
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Robert F Krueger
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA
| | | | - Philipp D Koellinger
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, the Netherlands
- Department of Complex Trait Genetics, Vrije Universiteit, Center for Neurogenomics and Cognitive Research, Amsterdam, the Netherlands
- Amsterdam Business School, University of Amsterdam, Amsterdam, the Netherlands
| | - Daniel J Benjamin
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA
| | - Meike Bartels
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands
- EMGO+ Institute for Health and Care Research, Amsterdam, the Netherlands
- Neuroscience Campus Amsterdam, Amsterdam, the Netherlands
| | - David Cesarini
- Department of Economics, New York University, New York, New York, USA
- Research Institute for Industrial Economics, Stockholm, Sweden
| |
Collapse
|
43
|
Okbay A, Beauchamp JP, Fontana MA, Lee JJ, Pers TH, Rietveld CA, Turley P, Chen GB, Emilsson V, Meddens SFW, Oskarsson S, Pickrell JK, Thom K, Timshel P, de Vlaming R, Abdellaoui A, Ahluwalia TS, Bacelis J, Baumbach C, Bjornsdottir G, Brandsma JH, Pina Concas M, Derringer J, Furlotte NA, Galesloot TE, Girotto G, Gupta R, Hall LM, Harris SE, Hofer E, Horikoshi M, Huffman JE, Kaasik K, Kalafati IP, Karlsson R, Kong A, Lahti J, van der Lee SJ, deLeeuw C, Lind PA, Lindgren KO, Liu T, Mangino M, Marten J, Mihailov E, Miller MB, van der Most PJ, Oldmeadow C, Payton A, Pervjakova N, Peyrot WJ, Qian Y, Raitakari O, Rueedi R, Salvi E, Schmidt B, Schraut KE, Shi J, Smith AV, Poot RA, St Pourcain B, Teumer A, Thorleifsson G, Verweij N, Vuckovic D, Wellmann J, Westra HJ, Yang J, Zhao W, Zhu Z, Alizadeh BZ, Amin N, Bakshi A, Baumeister SE, Biino G, Bønnelykke K, Boyle PA, Campbell H, Cappuccio FP, Davies G, De Neve JE, Deloukas P, Demuth I, Ding J, Eibich P, Eisele L, Eklund N, Evans DM, Faul JD, Feitosa MF, Forstner AJ, Gandin I, Gunnarsson B, Halldórsson BV, Harris TB, Heath AC, Hocking LJ, Holliday EG, Homuth G, Horan MA, Hottenga JJ, de Jager PL, Joshi PK, Jugessur A, Kaakinen MA, Kähönen M, Kanoni S, Keltigangas-Järvinen L, Kiemeney LALM, Kolcic I, Koskinen S, Kraja AT, Kroh M, Kutalik Z, Latvala A, Launer LJ, Lebreton MP, Levinson DF, Lichtenstein P, Lichtner P, Liewald DCM, Loukola A, Madden PA, Mägi R, Mäki-Opas T, Marioni RE, Marques-Vidal P, Meddens GA, McMahon G, Meisinger C, Meitinger T, Milaneschi Y, Milani L, Montgomery GW, Myhre R, Nelson CP, Nyholt DR, Ollier WER, Palotie A, Paternoster L, Pedersen NL, Petrovic KE, Porteous DJ, Räikkönen K, Ring SM, Robino A, Rostapshova O, Rudan I, Rustichini A, Salomaa V, Sanders AR, Sarin AP, Schmidt H, Scott RJ, Smith BH, Smith JA, Staessen JA, Steinhagen-Thiessen E, Strauch K, Terracciano A, Tobin MD, Ulivi S, Vaccargiu S, Quaye L, van Rooij FJA, Venturini C, Vinkhuyzen AAE, Völker U, Völzke H, Vonk JM, Vozzi D, Waage J, Ware EB, Willemsen G, Attia JR, Bennett DA, Berger K, Bertram L, Bisgaard H, Boomsma DI, Borecki IB, Bültmann U, Chabris CF, Cucca F, Cusi D, Deary IJ, Dedoussis GV, van Duijn CM, Eriksson JG, Franke B, Franke L, Gasparini P, Gejman PV, Gieger C, Grabe HJ, Gratten J, Groenen PJF, Gudnason V, van der Harst P, Hayward C, Hinds DA, Hoffmann W, Hyppönen E, Iacono WG, Jacobsson B, Järvelin MR, Jöckel KH, Kaprio J, Kardia SLR, Lehtimäki T, Lehrer SF, Magnusson PKE, Martin NG, McGue M, Metspalu A, Pendleton N, Penninx BWJH, Perola M, Pirastu N, Pirastu M, Polasek O, Posthuma D, Power C, Province MA, Samani NJ, Schlessinger D, Schmidt R, Sørensen TIA, Spector TD, Stefansson K, Thorsteinsdottir U, Thurik AR, Timpson NJ, Tiemeier H, Tung JY, Uitterlinden AG, Vitart V, Vollenweider P, Weir DR, Wilson JF, Wright AF, Conley DC, Krueger RF, Davey Smith G, Hofman A, Laibson DI, Medland SE, Meyer MN, Yang J, Johannesson M, Visscher PM, Esko T, Koellinger PD, Cesarini D, Benjamin DJ. Genome-wide association study identifies 74 loci associated with educational attainment. Nature 2016; 533:539-42. [PMID: 27225129 PMCID: PMC4883595 DOI: 10.1038/nature17671] [Citation(s) in RCA: 733] [Impact Index Per Article: 91.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2015] [Accepted: 03/16/2016] [Indexed: 01/15/2023]
Abstract
Educational attainment is strongly influenced by social and other environmental factors, but genetic factors are estimated to account for at least 20% of the variation across individuals. Here we report the results of a genome-wide association study (GWAS) for educational attainment that extends our earlier discovery sample of 101,069 individuals to 293,723 individuals, and a replication study in an independent sample of 111,349 individuals from the UK Biobank. We identify 74 genome-wide significant loci associated with the number of years of schooling completed. Single-nucleotide polymorphisms associated with educational attainment are disproportionately found in genomic regions regulating gene expression in the fetal brain. Candidate genes are preferentially expressed in neural tissue, especially during the prenatal period, and enriched for biological pathways involved in neural development. Our findings demonstrate that, even for a behavioural phenotype that is mostly environmentally determined, a well-powered GWAS identifies replicable associated genetic variants that suggest biologically relevant pathways. Because educational attainment is measured in large numbers of individuals, it will continue to be useful as a proxy phenotype in efforts to characterize the genetic influences of related phenotypes, including cognition and neuropsychiatric diseases.
Collapse
Affiliation(s)
- Aysu Okbay
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, 3062 PA, The Netherlands
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, 3062 PA, The Netherlands
| | - Jonathan P Beauchamp
- Department of Economics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - Mark Alan Fontana
- Center for Economic and Social Research, University of Southern California, Los Angeles, California 90089-3332, USA
| | - James J Lee
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455, USA
| | - Tune H Pers
- Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 2116, USA
- Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen 2100, Denmark
- Statens Serum Institut, Department of Epidemiology Research, Copenhagen 2300, Denmark
| | - Cornelius A Rietveld
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, 3062 PA, The Netherlands
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, 3062 PA, The Netherlands
| | - Patrick Turley
- Department of Economics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - Guo-Bo Chen
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Valur Emilsson
- Icelandic Heart Association, Kopavogur 201, Iceland
- Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík 107, Iceland
| | - S Fleur W Meddens
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, 3062 PA, The Netherlands
- Department of Complex Trait Genetics, VU University, Center for Neurogenomics and Cognitive Research, Amsterdam, 1081 HV, The Netherlands
- Amsterdam Business School, University of Amsterdam, Amsterdam, 1018 TV, The Netherlands
| | - Sven Oskarsson
- Department of Government, Uppsala University, Uppsala 751 20, Sweden
| | | | - Kevin Thom
- Department of Economics, New York University, New York, New York 10012, USA
| | - Pascal Timshel
- Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
- Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark Lyngby 2800, Denmark
| | - Ronald de Vlaming
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, 3062 PA, The Netherlands
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, 3062 PA, The Netherlands
| | - Abdel Abdellaoui
- Department of Biological Psychology, VU University Amsterdam, Amsterdam, 1081 BT, The Netherlands
| | - Tarunveer S Ahluwalia
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen 2100, Denmark
- COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen 2820, Denmark
- Steno Diabetes Center, Gentofte 2820, Denmark
| | - Jonas Bacelis
- Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg 416 85, Sweden
| | - Clemens Baumbach
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany
- Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | | | - Johannes H Brandsma
- Department of Cell Biology, Erasmus Medical Center Rotterdam, 3015 CN, The Netherlands
| | - Maria Pina Concas
- Istituto di Ricerca Genetica e Biomedica U.O.S. di Sassari, National Research Council of Italy, Sassari 07100, Italy
| | - Jaime Derringer
- Psychology, University of Illinois, Champaign, Illinois 61820, USA
| | | | - Tessel E Galesloot
- Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, 6500 HB, The Netherlands
| | - Giorgia Girotto
- Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste 34100, Italy
| | - Richa Gupta
- Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
| | - Leanne M Hall
- Department of Cardiovascular Sciences, University of Leicester, Leicester LE3 9QP, UK
- NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester LE3 9QP, UK
| | - Sarah E Harris
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Edith Hofer
- Department of Neurology, General Hospital and Medical University Graz, Graz 8036, Austria
- Institute for Medical Informatics, Statistics and Documentation, General Hospital and Medical University Graz, Graz 8036, Austria
| | - Momoko Horikoshi
- Oxford Centre for Diabetes, Endocrinology &Metabolism, University of Oxford, Oxford OX3 7LE, UK
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
| | - Jennifer E Huffman
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Kadri Kaasik
- Institute of Behavioural Sciences, University of Helsinki, 00014 Helsinki, Finland
| | - Ioanna P Kalafati
- Nutrition and Dietetics, Health Science and Education, Harokopio University, Athens 17671, Greece
| | - Robert Karlsson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 77, Sweden
| | | | - Jari Lahti
- Institute of Behavioural Sciences, University of Helsinki, 00014 Helsinki, Finland
- Folkhälsan Research Centre, 00014 Helsingfors, Finland
| | - Sven J van der Lee
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
| | - Christiaan deLeeuw
- Department of Complex Trait Genetics, VU University, Center for Neurogenomics and Cognitive Research, Amsterdam, 1081 HV, The Netherlands
- Institute for Computing and Information Sciences, Radboud University Nijmegen, Nijmegen, 6525 EC, The Netherlands
| | - Penelope A Lind
- Quantitative Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia
| | | | - Tian Liu
- Lifespan Psychology, Max Planck Institute for Human Development, Berlin 14195, Germany
| | - Massimo Mangino
- Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK
- NIHR Biomedical Research Centre, Guy's and St. Thomas' Foundation Trust, London SE1 7EH, UK
| | - Jonathan Marten
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Evelin Mihailov
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - Michael B Miller
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455, USA
| | - Peter J van der Most
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, 9700 RB, The Netherlands
| | - Christopher Oldmeadow
- Public Health Stream, Hunter Medical Research Institute, New Lambton, NSW 2305, Australia
- Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW 2300, Australia
| | - Antony Payton
- Centre for Integrated Genomic Medical Research, Institute of Population Health, The University of Manchester, Manchester M13 9PT, UK
- Human Communication and Deafness, School of Psychological Sciences, The University of Manchester, Manchester M13 9PL, UK
| | - Natalia Pervjakova
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
- Department of Health, THL-National Institute for Health and Welfare, 00271 Helsinki, Finland
| | - Wouter J Peyrot
- Psychiatry, VU University Medical Center &GGZ inGeest, Amsterdam, 1081 HL, The Netherlands
| | - Yong Qian
- Laboratory of Genetics, National Institute on Aging, Baltimore, Maryland 21224, USA
| | - Olli Raitakari
- Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, 20521 Turku, Finland
| | - Rico Rueedi
- Department of Medical Genetics, University of Lausanne, Lausanne 1005, Switzerland
- Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland
| | - Erika Salvi
- Department Of Health Sciences, University of Milan, Milano 20142, Italy
| | - Börge Schmidt
- Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen 45147, Germany
| | - Katharina E Schraut
- Centre for Global Health Research, The Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH8 9AG, UK
| | - Jianxin Shi
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892-9780, USA
| | - Albert V Smith
- Icelandic Heart Association, Kopavogur 201, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik 101, Iceland
| | - Raymond A Poot
- Department of Cell Biology, Erasmus Medical Center Rotterdam, 3015 CN, The Netherlands
| | - Beate St Pourcain
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK
- School of Oral and Dental Sciences, University of Bristol, Bristol BS1 2LY, UK
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, Greifswald 17475, Germany
| | | | - Niek Verweij
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, 9700 RB, The Netherlands
| | - Dragana Vuckovic
- Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste 34100, Italy
| | - Juergen Wellmann
- Institute of Epidemiology and Social Medicine, University of Münster, Münster 48149, Germany
| | - Harm-Jan Westra
- Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
- Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
- Partners Center for Personalized Genetic Medicine, Boston, Massachusetts 02115, USA
| | - Jingyun Yang
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
| | - Wei Zhao
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Zhihong Zhu
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Behrooz Z Alizadeh
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, 9700 RB, The Netherlands
- Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, 9713 GZ, The Netherlands
| | - Najaf Amin
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
| | - Andrew Bakshi
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Sebastian E Baumeister
- Institute for Community Medicine, University Medicine Greifswald, Greifswald 17475, Germany
- Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg D-93053, Germany
| | - Ginevra Biino
- Institute of Molecular Genetics, National Research Council of Italy, Pavia 27100, Italy
| | - Klaus Bønnelykke
- COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen 2820, Denmark
| | - Patricia A Boyle
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
| | - Harry Campbell
- Centre for Global Health Research, The Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH8 9AG, UK
| | | | - Gail Davies
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Department of Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | | | - Panos Deloukas
- William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
- Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders (PACER-HD), King Abdulaziz University, Jeddah 21589, Saudi Arabia
| | - Ilja Demuth
- The Berlin Aging Study II; Research Group on Geriatrics, Charité - Universitätsmedizin Berlin, Germany, Berlin 13347, Germany
- Institute of Medical and Human Genetics, Charité-Universitätsmedizin, Berlin, Berlin 13353, Germany
| | - Jun Ding
- Laboratory of Genetics, National Institute on Aging, Baltimore, Maryland 21224, USA
| | - Peter Eibich
- German Socio- Economic Panel Study, DIW Berlin, Berlin 10117, Germany
- Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK
| | - Lewin Eisele
- Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen 45147, Germany
| | - Niina Eklund
- Department of Health, THL-National Institute for Health and Welfare, 00271 Helsinki, Finland
| | - David M Evans
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK
- The University of Queensland Diamantina Institute, The Translational Research Institute, Brisbane, QLD 4102, Australia
| | - Jessica D Faul
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Mary F Feitosa
- Department of Genetics, Division of Statistical Genomics, Washington University School of Medicine, St. Louis, Missouri 63018, USA
| | - Andreas J Forstner
- Institute of Human Genetics, University of Bonn, Bonn 53127, Germany
- Department of Genomics, Life and Brain Center, University of Bonn, Bonn 53127, Germany
| | - Ilaria Gandin
- Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste 34100, Italy
| | | | - Bjarni V Halldórsson
- deCODE Genetics/Amgen Inc., Reykjavik 101, Iceland
- Institute of Biomedical and Neural Engineering, School of Science and Engineering, Reykjavik University, Reykjavik 101, Iceland
| | - Tamara B Harris
- Laboratory of Epidemiology, Demography, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892-9205, USA
| | - Andrew C Heath
- Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | - Lynne J Hocking
- Division of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
| | - Elizabeth G Holliday
- Public Health Stream, Hunter Medical Research Institute, New Lambton, NSW 2305, Australia
- Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW 2300, Australia
| | - Georg Homuth
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald 17475, Germany
| | - Michael A Horan
- Manchester Medical School, The University of Manchester, Manchester M13 9PT, UK
| | - Jouke-Jan Hottenga
- Department of Biological Psychology, VU University Amsterdam, Amsterdam, 1081 BT, The Netherlands
| | - Philip L de Jager
- Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
- Program in Translational NeuroPsychiatric Genomics, Departments of Neurology &Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA
- Harvard Medical School, Boston, Massachusetts 02115, USA
| | - Peter K Joshi
- Centre for Global Health Research, The Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH8 9AG, UK
| | - Astanand Jugessur
- Department of Genes and Environment, Norwegian Institute of Public Health, N-0403 Oslo, Norway
| | - Marika A Kaakinen
- Department of Genomics of Common Disease, Imperial College London, London, W12 0NN, UK
| | - Mika Kähönen
- Department of Clinical Physiology, Tampere University Hospital, 33521 Tampere, Finland
- Department of Clinical Physiology, University of Tampere, School of Medicine, 33014 Tampere, Finland
| | - Stavroula Kanoni
- William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
| | | | - Lambertus A L M Kiemeney
- Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, 6500 HB, The Netherlands
| | - Ivana Kolcic
- Public Health, Medical School, University of Split, 21000 Split, Croatia
| | - Seppo Koskinen
- Department of Health, THL-National Institute for Health and Welfare, 00271 Helsinki, Finland
| | - Aldi T Kraja
- Department of Genetics, Division of Statistical Genomics, Washington University School of Medicine, St. Louis, Missouri 63018, USA
| | - Martin Kroh
- German Socio- Economic Panel Study, DIW Berlin, Berlin 10117, Germany
| | - Zoltan Kutalik
- Department of Medical Genetics, University of Lausanne, Lausanne 1005, Switzerland
- Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland
- Institute of Social and Preventive Medicine, Lausanne University Hospital (CHUV), Lausanne 1010, Switzerland
| | - Antti Latvala
- Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
| | - Lenore J Launer
- Neuroepidemiology Section, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892-9205, USA
| | - Maël P Lebreton
- Amsterdam Business School, University of Amsterdam, Amsterdam, 1018 TV, The Netherlands
- Amsterdam Brain and Cognition Center, University of Amsterdam, Amsterdam, 1018 XA, The Netherlands
| | - Douglas F Levinson
- Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California 94305-5797, USA
| | - Paul Lichtenstein
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 77, Sweden
| | - Peter Lichtner
- Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - David C M Liewald
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Department of Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | | | - Anu Loukola
- Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
| | - Pamela A Madden
- Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA
| | - Reedik Mägi
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - Tomi Mäki-Opas
- Department of Health, THL-National Institute for Health and Welfare, 00271 Helsinki, Finland
| | - Riccardo E Marioni
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK
| | - Pedro Marques-Vidal
- Department of Internal Medicine, Internal Medicine, Lausanne University Hospital (CHUV), Lausanne 1011, Switzerland
| | | | - George McMahon
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK
| | - Christa Meisinger
- Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Thomas Meitinger
- Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Yusplitri Milaneschi
- Psychiatry, VU University Medical Center &GGZ inGeest, Amsterdam, 1081 HL, The Netherlands
| | - Lili Milani
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - Grant W Montgomery
- Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia
| | - Ronny Myhre
- Department of Genes and Environment, Norwegian Institute of Public Health, N-0403 Oslo, Norway
| | - Christopher P Nelson
- Department of Cardiovascular Sciences, University of Leicester, Leicester LE3 9QP, UK
- NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester LE3 9QP, UK
| | - Dale R Nyholt
- Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia
- Institute of Health and Biomedical Innovation, Queensland Institute of Technology, Brisbane, QLD 4059, Australia
| | - William E R Ollier
- Centre for Integrated Genomic Medical Research, Institute of Population Health, The University of Manchester, Manchester M13 9PT, UK
| | - Aarno Palotie
- Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
- Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- The Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
- Psychiatric &Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland
- Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
| | - Lavinia Paternoster
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK
| | - Nancy L Pedersen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 77, Sweden
| | - Katja E Petrovic
- Department of Neurology, General Hospital and Medical University Graz, Graz 8036, Austria
| | - David J Porteous
- Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Katri Räikkönen
- Institute of Behavioural Sciences, University of Helsinki, 00014 Helsinki, Finland
- Folkhälsan Research Centre, 00014 Helsingfors, Finland
| | - Susan M Ring
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK
| | - Antonietta Robino
- Medical Genetics, Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste 34100, Italy
| | - Olga Rostapshova
- Department of Economics, Harvard University, Cambridge, Massachusetts 02138, USA
- Social Impact, Arlington, Virginia 22201, USA
| | - Igor Rudan
- Centre for Global Health Research, The Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH8 9AG, UK
| | - Aldo Rustichini
- Department of Economics, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455, USA
| | - Veikko Salomaa
- Department of Health, THL-National Institute for Health and Welfare, 00271 Helsinki, Finland
| | - Alan R Sanders
- Department of Psychiatry and Behavioral Sciences, NorthShore University HealthSystem, Evanston, Illinois 60201-3137, USA
- Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois 60637, USA
| | - Antti-Pekka Sarin
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland
- Public Health Genomics Unit, National Institute for Health and Welfare, 00300 Helsinki, Finland
| | - Helena Schmidt
- Department of Neurology, General Hospital and Medical University Graz, Graz 8036, Austria
- Research Unit for Genetic Epidemiology, Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, General Hospital and Medical University, Graz, Graz 8010, Austria
| | - Rodney J Scott
- Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW 2300, Australia
- Information Based Medicine Stream, Hunter Medical Research Institute, New Lambton, NSW 2305, Australia
| | - Blair H Smith
- Medical Research Institute, University of Dundee, Dundee DD1 9SY, UK
| | - Jennifer A Smith
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Jan A Staessen
- Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Science, University of Leuven, Leuven 3000, Belgium
- R&D VitaK Group, Maastricht University, Maastricht, 6229 EV, The Netherlands
| | - Elisabeth Steinhagen-Thiessen
- The Berlin Aging Study II; Research Group on Geriatrics, Charité - Universitätsmedizin Berlin, Germany, Berlin 13347, Germany
| | - Konstantin Strauch
- Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic Epidemiology, Ludwig Maximilians-Universität, Munich 81377, Germany
| | - Antonio Terracciano
- Department of Geriatrics, Florida State University College of Medicine, Tallahassee, Florida 32306, USA
| | - Martin D Tobin
- Department of Health Sciences and Genetics, University of Leicester, Leicester LE1 7RH, UK
| | - Sheila Ulivi
- Medical Genetics, Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste 34100, Italy
| | - Simona Vaccargiu
- Istituto di Ricerca Genetica e Biomedica U.O.S. di Sassari, National Research Council of Italy, Sassari 07100, Italy
| | - Lydia Quaye
- Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK
| | - Frank J A van Rooij
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
| | - Cristina Venturini
- Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK
- NIHR Biomedical Research Centre, Guy's and St. Thomas' Foundation Trust, London SE1 7EH, UK
| | - Anna A E Vinkhuyzen
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Uwe Völker
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald 17475, Germany
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald 17475, Germany
| | - Judith M Vonk
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, 9700 RB, The Netherlands
| | - Diego Vozzi
- Social Impact, Arlington, Virginia 22201, USA
| | - Johannes Waage
- COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen 2820, Denmark
- Steno Diabetes Center, Gentofte 2820, Denmark
| | - Erin B Ware
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan 48109, USA
- Research Center for Group Dynamics, Institute for Social Research, University of Michigan, Ann Arbor, Michigan 48104, USA
| | - Gonneke Willemsen
- Department of Biological Psychology, VU University Amsterdam, Amsterdam, 1081 BT, The Netherlands
| | - John R Attia
- Public Health Stream, Hunter Medical Research Institute, New Lambton, NSW 2305, Australia
- Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW 2300, Australia
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
| | - Klaus Berger
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, 9700 RB, The Netherlands
| | - Lars Bertram
- Platform for Genome Analytics, Institutes of Neurogenetics &Integrative and Experimental Genomics, University of Lübeck, Lübeck 23562, Germany
- Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London SW7 2AZ, UK
| | - Hans Bisgaard
- COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen 2820, Denmark
| | - Dorret I Boomsma
- Department of Biological Psychology, VU University Amsterdam, Amsterdam, 1081 BT, The Netherlands
| | - Ingrid B Borecki
- Department of Genetics, Division of Statistical Genomics, Washington University School of Medicine, St. Louis, Missouri 63018, USA
| | - Ute Bültmann
- Department of Health Sciences, Community &Occupational Medicine, University of Groningen, University Medical Center Groningen, Groningen, 9713 AV, The Netherlands
| | | | - Francesco Cucca
- Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche, c/o Cittadella Universitaria di Monserrato, Monserrato, Cagliari 9042, Italy
| | - Daniele Cusi
- Department Of Health Sciences, University of Milan, Milano 20142, Italy
- Institute of Biomedical Technologies, Italian National Research Council, Segrate (Milano) 20090, Italy
| | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Department of Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - George V Dedoussis
- Nutrition and Dietetics, Health Science and Education, Harokopio University, Athens 17671, Greece
| | - Cornelia M van Duijn
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
| | - Johan G Eriksson
- Folkhälsan Research Centre, 00014 Helsingfors, Finland
- Department of General Practice and Primary Health Care, University of Helsinki, 00014 Helsinki, Finland
| | - Barbara Franke
- Departments of Human Genetics and Psychiatry, Donders Centre for Neuroscience, Nijmegen, 6500 HB, The Netherlands
| | - Lude Franke
- Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, 9700 RB, The Netherlands
| | - Paolo Gasparini
- Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste 34100, Italy
- Medical Genetics, Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste 34100, Italy
- Sidra, Experimental Genetics Division, Sidra, Doha 26999, Qatar
| | - Pablo V Gejman
- Department of Psychiatry and Behavioral Sciences, NorthShore University HealthSystem, Evanston, Illinois 60201-3137, USA
- Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois 60637, USA
| | - Christian Gieger
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Hans-Jörgen Grabe
- Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald 17475, Germany
- Department of Psychiatry and Psychotherapy, HELIOS-Hospital Stralsund, Stralsund 18437, Germany
| | - Jacob Gratten
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Patrick J F Groenen
- Econometric Institute, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, 3062 PA, The Netherlands
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur 201, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik 101, Iceland
| | - Pim van der Harst
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, 9700 RB, The Netherlands
- Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, 9700 RB, The Netherlands
- Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, 1105 AZ, The Netherlands
| | - Caroline Hayward
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
- Generation Scotland, Centre for Genomics and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | | | - Wolfgang Hoffmann
- Institute for Community Medicine, University Medicine Greifswald, Greifswald 17475, Germany
| | - Elina Hyppönen
- Centre for Population Health Research, School of Health Sciences and Sansom Institute, University of South Australia, Adelaide, SA 5000, Australia
- South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia
- Population, Policy and Practice, UCL Institute of Child Health, London WC1N 1EH, UK
| | - William G Iacono
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455, USA
| | - Bo Jacobsson
- Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg 416 85, Sweden
- Department of Genes and Environment, Norwegian Institute of Public Health, N-0403 Oslo, Norway
| | - Marjo-Riitta Järvelin
- Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment &Health, School of Public Health, Imperial College London, London W2 1PG, UK
- Center for Life Course Epidemiology, Faculty of Medicine, University of Oulu, 90014 Oulu, Finland
- Unit of Primary Care, Oulu University Hospital, 90029 Oulu, Finland
- Biocenter Oulu, University of Oulu, 90014 Oulu, Finland
| | - Karl-Heinz Jöckel
- Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen 45147, Germany
| | - Jaakko Kaprio
- Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
- Department of Health, THL-National Institute for Health and Welfare, 00271 Helsinki, Finland
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland
| | - Sharon L R Kardia
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Terho Lehtimäki
- Fimlab Laboratories, 33520 Tampere, Finland
- Department of Clinical Chemistry, University of Tampere, School of Medicine, 33014 Tampere, Finland
| | - Steven F Lehrer
- Economics, NYU Shanghai, 200122 Pudong, China
- Policy Studies, Queen's University, Kingston, Ontario K7L 3N6, Canada
| | - Patrik K E Magnusson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 77, Sweden
| | - Nicholas G Martin
- Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia
| | - Matt McGue
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455, USA
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
- Institute of Molecular and Cell Biology, University of Tartu, Tartu 51010, Estonia
| | - Neil Pendleton
- Centre for Clinical and Cognitive Neuroscience, Institute Brain Behaviour and Mental Health, Salford Royal Hospital, Manchester M6 8HD, UK
- Manchester Institute for Collaborative Research in Ageing, University of Manchester, Manchester M13 9PL, UK
| | - Brenda W J H Penninx
- Psychiatry, VU University Medical Center &GGZ inGeest, Amsterdam, 1081 HL, The Netherlands
| | - Markus Perola
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
- Department of Health, THL-National Institute for Health and Welfare, 00271 Helsinki, Finland
| | - Nicola Pirastu
- Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste 34100, Italy
| | - Mario Pirastu
- Istituto di Ricerca Genetica e Biomedica U.O.S. di Sassari, National Research Council of Italy, Sassari 07100, Italy
| | - Ozren Polasek
- Centre for Global Health Research, The Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH8 9AG, UK
- Faculty of Medicine, University of Split, Split 21000, Croatia
| | - Danielle Posthuma
- Department of Complex Trait Genetics, VU University, Center for Neurogenomics and Cognitive Research, Amsterdam, 1081 HV, The Netherlands
- Department of Clinical Genetics, VU Medical Centre, Amsterdam, 1081 HV, The Netherlands
| | - Christine Power
- Population, Policy and Practice, UCL Institute of Child Health, London WC1N 1EH, UK
| | - Michael A Province
- Department of Genetics, Division of Statistical Genomics, Washington University School of Medicine, St. Louis, Missouri 63018, USA
| | - Nilesh J Samani
- Department of Cardiovascular Sciences, University of Leicester, Leicester LE3 9QP, UK
- NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester LE3 9QP, UK
| | - David Schlessinger
- Laboratory of Genetics, National Institute on Aging, Baltimore, Maryland 21224, USA
| | - Reinhold Schmidt
- Department of Neurology, General Hospital and Medical University Graz, Graz 8036, Austria
| | - Thorkild I A Sørensen
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen 2100, Denmark
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK
- Institute of Preventive Medicine. Bispebjerg and Frederiksberg Hospitals, The Capital Region, Frederiksberg 2000, Denmark
| | - Tim D Spector
- Department of Twin Research and Genetic Epidemiology, King's College London, London SE1 7EH, UK
| | - Kari Stefansson
- deCODE Genetics/Amgen Inc., Reykjavik 101, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik 101, Iceland
| | - Unnur Thorsteinsdottir
- deCODE Genetics/Amgen Inc., Reykjavik 101, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik 101, Iceland
| | - A Roy Thurik
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, 3062 PA, The Netherlands
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, 3062 PA, The Netherlands
- Montpellier Business School, Montpellier 34080, France
- Panteia, Zoetermeer, 2715 CA, The Netherlands
| | - Nicholas J Timpson
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK
| | - Henning Tiemeier
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
- Department of Psychiatry, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
- Department of Child and Adolescent Psychiatry, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
| | - Joyce Y Tung
- 23andMe, Inc., Mountain View, California 94041, USA
| | - André G Uitterlinden
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
| | - Veronique Vitart
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Peter Vollenweider
- Department of Internal Medicine, Internal Medicine, Lausanne University Hospital (CHUV), Lausanne 1011, Switzerland
| | - David R Weir
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - James F Wilson
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
- Centre for Global Health Research, The Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH8 9AG, UK
| | - Alan F Wright
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Dalton C Conley
- Department of Sociology, New York University, New York, New York 10012, USA
- School of Medicine, New York University, New York, New York 10016, USA
| | - Robert F Krueger
- Department of Psychology, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455, USA
| | - George Davey Smith
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK
| | - Albert Hofman
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, 3015 GE, The Netherlands
| | - David I Laibson
- Department of Economics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - Sarah E Medland
- Quantitative Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia
| | - Michelle N Meyer
- Bioethics Program, Union Graduate College - Icahn School of Medicine at Mount Sinai, Schenectady, New York 12308, USA
| | - Jian Yang
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia
- The University of Queensland Diamantina Institute, The Translational Research Institute, Brisbane, QLD 4102, Australia
| | - Magnus Johannesson
- Department of Economics, Stockholm School of Economics, Stockholm 113 83, Sweden
| | - Peter M Visscher
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia
- The University of Queensland Diamantina Institute, The Translational Research Institute, Brisbane, QLD 4102, Australia
| | - Tõnu Esko
- Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 2116, USA
- Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
- Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA
| | - Philipp D Koellinger
- Erasmus University Rotterdam Institute for Behavior and Biology, Rotterdam, 3062 PA, The Netherlands
- Department of Complex Trait Genetics, VU University, Center for Neurogenomics and Cognitive Research, Amsterdam, 1081 HV, The Netherlands
- Amsterdam Business School, University of Amsterdam, Amsterdam, 1018 TV, The Netherlands
| | - David Cesarini
- Department of Economics, New York University, New York, New York 10012, USA
- Research Institute for Industrial Economics, Stockholm 10215, Sweden
| | - Daniel J Benjamin
- Center for Economic and Social Research, University of Southern California, Los Angeles, California 90089-3332, USA
| |
Collapse
|
44
|
|
45
|
Rietveld CA, Medland SE, Derringer J, Yang J, Esko T, Martin NW, Westra HJ, Shakhbazov K, Abdellaoui A, Agrawal A, Albrecht E, Alizadeh BZ, Amin N, Barnard J, Baumeister SE, Benke KS, Bielak LF, Boatman JA, Boyle PA, Davies G, de Leeuw C, Eklund N, Evans DS, Ferhmann R, Fischer K, Gieger C, Gjessing HK, Hägg S, Harris JR, Hayward C, Holzapfel C, Ibrahim-Verbaas CA, Ingelsson E, Jacobsson B, Joshi PK, Jugessur A, Kaakinen M, Kanoni S, Karjalainen J, Kolcic I, Kristiansson K, Kutalik Z, Lahti J, Lee SH, Lin P, Lind PA, Liu Y, Lohman K, Loitfelder M, McMahon G, Vidal PM, Meirelles O, Milani L, Myhre R, Nuotio ML, Oldmeadow CJ, Petrovic KE, Peyrot WJ, Polašek O, Quaye L, Reinmaa E, Rice JP, Rizzi TS, Schmidt H, Schmidt R, Smith AV, Smith JA, Tanaka T, Terracciano A, van der Loos MJ, Vitart V, Völzke H, Wellmann J, Yu L, Zhao W, Allik J, Attia JR, Bandinelli S, Bastardot F, Beauchamp J, Bennett DA, Berger K, Bierut LJ, Boomsma DI, Bültmann U, Campbell H, Chabris CF, Cherkas L, Chung MK, Cucca F, de Andrade M, De Jager PL, De Neve JE, Deary IJ, Dedoussis GV, Deloukas P, Dimitriou M, Eiriksdottir G, Elderson MF, Eriksson JG, Evans DM, Faul JD, Ferrucci L, Garcia ME, Grönberg H, Gudnason V, Hall P, Harris JM, Harris TB, Hastie ND, Heath AC, Hernandez DG, Hoffmann W, Hofman A, Holle R, Holliday EG, Hottenga JJ, Iacono WG, Illig T, Järvelin MR, Kähönen M, Kaprio J, Kirkpatrick RM, Kowgier M, Latvala A, Launer LJ, Lawlor DA, Lehtimäki T, Li J, Lichtenstein P, Lichtner P, Liewald DC, Madden PA, Magnusson PKE, Mäkinen TE, Masala M, McGue M, Metspalu A, Mielck A, Miller MB, Montgomery GW, Mukherjee S, Nyholt DR, Oostra BA, Palmer LJ, Palotie A, Penninx B, Perola M, Peyser PA, Preisig M, Räikkönen K, Raitakari OT, Realo A, Ring SM, Ripatti S, Rivadeneira F, Rudan I, Rustichini A, Salomaa V, Sarin AP, Schlessinger D, Scott RJ, Snieder H, Pourcain BS, Starr JM, Sul JH, Surakka I, Svento R, Teumer A, Tiemeier H, Rooij FJA, Van Wagoner DR, Vartiainen E, Viikari J, Vollenweider P, Vonk JM, Waeber G, Weir DR, Wichmann HE, Widen E, Willemsen G, Wilson JF, Wright AF, Conley D, Davey-Smith G, Franke L, Groenen PJF, Hofman A, Johannesson M, Kardia SL, Krueger RF, Laibson D, Martin NG, Meyer MN, Posthuma D, Thurik AR, Timpson NJ, Uitterlinden AG, van Duijn CM, Visscher PM, Benjamin DJ, Cesarini D, Koellinger PD. GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science 2013; 340:1467-71. [PMID: 23722424 PMCID: PMC3751588 DOI: 10.1126/science.1235488] [Citation(s) in RCA: 476] [Impact Index Per Article: 43.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
A genome-wide association study (GWAS) of educational attainment was conducted in a discovery sample of 101,069 individuals and a replication sample of 25,490. Three independent single-nucleotide polymorphisms (SNPs) are genome-wide significant (rs9320913, rs11584700, rs4851266), and all three replicate. Estimated effects sizes are small (coefficient of determination R(2) ≈ 0.02%), approximately 1 month of schooling per allele. A linear polygenic score from all measured SNPs accounts for ≈2% of the variance in both educational attainment and cognitive function. Genes in the region of the loci have previously been associated with health, cognitive, and central nervous system phenotypes, and bioinformatics analyses suggest the involvement of the anterior caudate nucleus. These findings provide promising candidate SNPs for follow-up work, and our effect size estimates can anchor power analyses in social-science genetics.
Collapse
Affiliation(s)
- Cornelius A. Rietveld
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands,Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands
| | - Sarah E. Medland
- Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4006, Australia
| | - Jaime Derringer
- Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO 80309–0447, USA
| | - Jian Yang
- University of Queensland Diamantina Institute, The University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia
| | - Tõnu Esko
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - Nicolas W. Martin
- Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4006, Australia,School of Psychology, University of Queensland, Brisbane, Queensland 4072, Australia
| | - Harm-Jan Westra
- Department of Genetics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| | - Konstantin Shakhbazov
- University of Queensland Diamantina Institute, The University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia,Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Abdel Abdellaoui
- Department of Biological Psychology, VU University Amsterdam, 1081 BT Amsterdam, The Netherlands
| | - Arpana Agrawal
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA
| | - Eva Albrecht
- Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Behrooz Z. Alizadeh
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands
| | - Najaf Amin
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, the Netherlands
| | - John Barnard
- Heart and Vascular and Lerner Research Institutes, Cleveland Clinic, Cleveland, OH 44195, USA
| | | | - Kelly S. Benke
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada
| | - Lawrence F. Bielak
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109–2029, USA
| | - Jeffrey A. Boatman
- Division of Biostatistics, University of Minnesota, Minneapolis, MN 55455, USA
| | - Patricia A. Boyle
- Rush University Medical Center, Rush Alzheimer’s Disease Center, Chicago, IL 60612, USA
| | - Gail Davies
- Centre for Cognitive Aging and Cognitive Epidemiology, The University of Edinburgh, Edinburgh EH8 9JZ, Scotland, UK
| | - Christiaan de Leeuw
- Department of Functional Genomics, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands
| | - Niina Eklund
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland,Public Health Genomics Unit, Department of Chronic Disease Prevention, The National Institute for Health and Welfare, Helsinki 00014, Finland
| | - Daniel S. Evans
- California Pacific Medical Center Research Institute, San Francisco, CA 94107–1728, USA
| | - Rudolf Ferhmann
- Department of Genetics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| | - Krista Fischer
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - Christian Gieger
- Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Håkon K. Gjessing
- Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, N-0403 Oslo, Norway
| | - Sara Hägg
- Molecular Epidemiology, Department of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden,Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden
| | - Jennifer R. Harris
- Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, N-0403 Oslo, Norway
| | - Caroline Hayward
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Christina Holzapfel
- Else Kroener-Fresenius-Centre for Nutritional Medicine, Technische Universität München, 81675 Munich, Germany,Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Carla A. Ibrahim-Verbaas
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, the Netherlands,Department of Neurology, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands
| | - Erik Ingelsson
- Molecular Epidemiology, Department of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden,Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden
| | - Bo Jacobsson
- Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, N-0403 Oslo, Norway,Department of Obstetrics and Gynecology, Institute of Public Health, Sahlgrenska Academy, Sahgrenska University Hospital, Gothenburg, 413 45, Sweden
| | - Peter K. Joshi
- Centre for Population Health Sciences, The University of Edinburgh, Edinburgh EH8 9AG, UK
| | - Astanand Jugessur
- Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, N-0403 Oslo, Norway
| | - Marika Kaakinen
- Institute of Health Sciences, University of Oulu, Oulu 90014, Finland,Biocenter Oulu, University of Oulu, Oulu 90014, Finland
| | - Stavroula Kanoni
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK
| | - Juha Karjalainen
- Department of Genetics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| | - Ivana Kolcic
- Faculty of Medicine, University of Split, 21000 Split, Croatia
| | - Kati Kristiansson
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland,Public Health Genomics Unit, Department of Chronic Disease Prevention, The National Institute for Health and Welfare, Helsinki 00014, Finland
| | - Zoltán Kutalik
- Department of Medical Genetics, University of Lausanne, 1005 Lausanne, Switzerland,Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland
| | - Jari Lahti
- Institute of Behavioral Sciences, University of Helsinki, Helsinki 00014, Finland
| | - Sang H. Lee
- Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4006, Australia
| | - Peng Lin
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA
| | - Penelope A. Lind
- Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4006, Australia
| | - Yongmei Liu
- Department of Epidemiology & Prevention, Division of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem, NC 27157–1063, USA
| | - Kurt Lohman
- Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem, NC 27157–1063, USA
| | - Marisa Loitfelder
- Division for Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz 8036, Austria
| | - George McMahon
- School of Social and Community Medicine, University of Bristol, Bristol BS8 2PR, UK
| | - Pedro Marques Vidal
- Institute of Social and Preventive Medicine, Lausanne University Hospital, 1005 Lausanne, Switzerland
| | - Osorio Meirelles
- National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Lili Milani
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - Ronny Myhre
- Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, N-0403 Oslo, Norway
| | - Marja-Liisa Nuotio
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland,Public Health Genomics Unit, Department of Chronic Disease Prevention, The National Institute for Health and Welfare, Helsinki 00014, Finland
| | - Christopher J. Oldmeadow
- Hunter Medical Research Institute and Faculty of Health, University of Newcastle, Newcastle, NSW 2308, Australia
| | - Katja E. Petrovic
- Division of General Neurology, Department of Neurology, General Hospital and Medical University of Graz, Graz 8036, Austria
| | - Wouter J. Peyrot
- Department of Psychiatry, VU University Medical Center, 1081 HL Amsterdam, The Netherlands
| | - Ozren Polašek
- Faculty of Medicine, University of Split, 21000 Split, Croatia
| | - Lydia Quaye
- Department of Twin Research and Genetic Epidemiology, King’s College London, London SE1 7EH, UK
| | - Eva Reinmaa
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - John P. Rice
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA
| | - Thais S. Rizzi
- Department of Functional Genomics, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands
| | - Helena Schmidt
- Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz 8036, Austria
| | - Reinhold Schmidt
- Division for Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz 8036, Austria
| | - Albert V. Smith
- Icelandic Heart Association, Kopavogur 201, Iceland,Department of Medicine, University of Iceland, Reykjavik 101, Iceland
| | - Jennifer A. Smith
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109–2029, USA
| | - Toshiko Tanaka
- National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Antonio Terracciano
- National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA,College of Medicine, Florida State University, Tallahassee, FL 32306–4300, USA
| | - Matthijs J.H.M. van der Loos
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands,Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands
| | - Veronique Vitart
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald 17489, Germany
| | - Jürgen Wellmann
- Institute of Epidemiology and Social Medicine, University of Muenster, 48129 Muenster, Germany
| | - Lei Yu
- Rush University Medical Center, Rush Alzheimer’s Disease Center, Chicago, IL 60612, USA
| | - Wei Zhao
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109–2029, USA
| | - Jüri Allik
- Department of Psychology, University of Tartu, Tartu 50410, Estonia
| | - John R. Attia
- Hunter Medical Research Institute and Faculty of Health, University of Newcastle, Newcastle, NSW 2308, Australia
| | | | - François Bastardot
- Department of Internal Medicine, University Hospital, 1011 Lausanne, Switzerland
| | | | - David A. Bennett
- Rush University Medical Center, Rush Alzheimer’s Disease Center, Chicago, IL 60612, USA
| | - Klaus Berger
- Institute of Epidemiology and Social Medicine, University of Muenster, 48129 Muenster, Germany
| | - Laura J. Bierut
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA
| | - Dorret I. Boomsma
- Department of Biological Psychology, VU University Amsterdam, 1081 BT Amsterdam, The Netherlands
| | - Ute Bültmann
- Department of Health Sciences, Community & Occupational Medicine, University Medical Center Groningen, 9700 AD Groningen, The Netherlands
| | - Harry Campbell
- Centre for Population Health Sciences, The University of Edinburgh, Edinburgh EH8 9AG, UK
| | | | - Lynn Cherkas
- Department of Twin Research and Genetic Epidemiology, King’s College London, London SE1 7EH, UK
| | - Mina K. Chung
- Heart and Vascular and Lerner Research Institutes, Cleveland Clinic, Cleveland, OH 44195, USA
| | - Francesco Cucca
- Istituto di Ricerca Genetica e Biomedica, CNR, Monserrato, 09042, Cagliari, Italy,Dipartimento di Scienze Biomediche, Università di Sassari, 07100 SS, Italy
| | - Mariza de Andrade
- Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA
| | - Philip L. De Jager
- Program in Translational Neuropsychiatric Genomics, Department of Neurology, Brigham and Women’s Hospital, Boston, MA 02115, USA
| | - Jan-Emmanuel De Neve
- School of Public Policy, University College London, London WC1H 9QU, UK,Centre for Economic Performance, London School of Economics, London WC2A 2AE, UK
| | - Ian J. Deary
- Centre for Cognitive Aging and Cognitive Epidemiology, The University of Edinburgh, Edinburgh EH8 9JZ, Scotland, UK,Department of Psychology, The University of Edinburgh, Edinburgh EH8 9JZ, Scotland, UK
| | - George V. Dedoussis
- Department of Nutrition and Dietetics, Harokopio University of Athens, Athens 17671, Greece
| | - Panos Deloukas
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK
| | - Maria Dimitriou
- Department of Nutrition and Dietetics, Harokopio University of Athens, Athens 17671, Greece
| | | | - Martin F. Elderson
- LifeLines Cohort Study, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands
| | - Johan G. Eriksson
- Department of General Practice and Primary Health Care, University of Helsinki, Helsinki 00014, Finland,Unit of General Practice, Helsinki University Central Hospital, Helsinki 00280, Finland,Folkhälsan Research Center, Helsinki 00250, Finland,Vaasa Central Hospital, Vaasa 65130, Finland
| | - David M. Evans
- MRC Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine, University of Bristol, Bristol BS8 2PR, UK
| | - Jessica D. Faul
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI 48106, USA
| | - Luigi Ferrucci
- National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Melissa E. Garcia
- National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Henrik Grönberg
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur 201, Iceland,Department of Medicine, University of Iceland, Reykjavik 101, Iceland
| | - Per Hall
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden
| | - Juliette M. Harris
- Department of Twin Research and Genetic Epidemiology, King’s College London, London SE1 7EH, UK
| | - Tamara B. Harris
- National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Nicholas D. Hastie
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Andrew C. Heath
- Division of Biology and Biomedical Sciences, Washington University, St. Louis, MO 63110–1093, USA
| | - Dena G. Hernandez
- National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Wolfgang Hoffmann
- Institute for Community Medicine, University Medicine Greifswald, Greifswald 17489, Germany
| | - Adriaan Hofman
- Faculty of Behavioral and Social Sciences, University of Groningen, 9747 AD Groningen, The Netherlands
| | - Rolf Holle
- Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Elizabeth G. Holliday
- Hunter Medical Research Institute and Faculty of Health, University of Newcastle, Newcastle, NSW 2308, Australia
| | - Jouke-Jan Hottenga
- Department of Biological Psychology, VU University Amsterdam, 1081 BT Amsterdam, The Netherlands
| | - William G. Iacono
- Department of Psychology, University of Minnesota, Minneapolis, MN 55455–0344, USA
| | - Thomas Illig
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany,Hannover Unified Biobank, Hannover Medical School, 30625 Hannover, Germany
| | - Marjo-Riitta Järvelin
- Institute of Health Sciences, University of Oulu, Oulu 90014, Finland,Biocenter Oulu, University of Oulu, Oulu 90014, Finland,Department of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, Imperial College London, London W2 1PG, UK,Unit of Primary Care, Oulu University Hospital, Oulu 90220, Finland,Department of Children and Young People and Families, National Institute for Health and Welfare, Oulu 90101, Finland
| | - Mika Kähönen
- Department of Clinical Physiology, Tampere University Hospital and University of Tampere School of Medicine, Tampere 33520, Finland
| | - Jaakko Kaprio
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland,Department of Public Health, University of Helsinki, 00014 Helsinki, Finland,Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, 00300 Helsinki, Finland
| | | | - Matthew Kowgier
- Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada
| | - Antti Latvala
- Department of Public Health, University of Helsinki, 00014 Helsinki, Finland,Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, 00300 Helsinki, Finland
| | - Lenore J. Launer
- National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Debbie A. Lawlor
- MRC Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine, University of Bristol, Bristol BS8 2PR, UK
| | - Terho Lehtimäki
- Department of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital, Tampere 33520, Finland
| | - Jingmei Li
- Human Genetics, Genome Institute of Singapore, Singapore 138672, Singapore
| | - Paul Lichtenstein
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden
| | - Peter Lichtner
- Institute of Human Genetics, Helmholtz Centre Munich, German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - David C. Liewald
- Centre for Cognitive Aging and Cognitive Epidemiology, The University of Edinburgh, Edinburgh EH8 9JZ, Scotland, UK
| | - Pamela A. Madden
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA
| | - Patrik K. E. Magnusson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden
| | - Tomi E. Mäkinen
- Department of Health, Functional Capacity and Welfare, National Institute for Health and Welfare, Helsinki 00271, Finland
| | - Marco Masala
- Istituto di Ricerca Genetica e Biomedica, CNR, Monserrato, 09042, Cagliari, Italy
| | - Matt McGue
- Department of Psychology, University of Minnesota, Minneapolis, MN 55455–0344, USA
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - Andreas Mielck
- Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Michael B. Miller
- Department of Psychology, University of Minnesota, Minneapolis, MN 55455–0344, USA
| | - Grant W. Montgomery
- Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4006, Australia
| | - Sutapa Mukherjee
- Western Australia Sleep Disorders Research Institute, Sir Charles Gairdner Hospital, Perth, Western Australia 6009, Australia,Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada,Women’s College Research Institute, University of Toronto, Toronto, Ontario M5G 1N8, Canada
| | - Dale R. Nyholt
- Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4006, Australia
| | - Ben A. Oostra
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, the Netherlands
| | - Lyle J. Palmer
- Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada
| | - Aarno Palotie
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland,Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK,Department of Medical Genetics, University of Helsinki, 00014 Helsinki, Finland
| | - Brenda Penninx
- Department of Psychiatry, VU University Medical Center, 1081 HL Amsterdam, The Netherlands
| | - Markus Perola
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia,Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland,Public Health Genomics Unit, Department of Chronic Disease Prevention, The National Institute for Health and Welfare, Helsinki 00014, Finland
| | - Patricia A. Peyser
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109–2029, USA
| | - Martin Preisig
- Department of Internal Medicine, University Hospital, 1011 Lausanne, Switzerland
| | - Katri Räikkönen
- Institute of Behavioral Sciences, University of Helsinki, Helsinki 00014, Finland
| | - Olli T. Raitakari
- Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku 20520, Finland,Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku 20520, Finland
| | - Anu Realo
- Department of Psychology, University of Tartu, Tartu 50410, Estonia
| | - Susan M. Ring
- School of Social and Community Medicine, University of Bristol, Bristol BS8 2PR, UK
| | - Samuli Ripatti
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland,Public Health Genomics Unit, Department of Chronic Disease Prevention, The National Institute for Health and Welfare, Helsinki 00014, Finland,Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK
| | - Fernando Rivadeneira
- Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands,Department of Internal Medicine, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands
| | - Igor Rudan
- Centre for Population Health Sciences, The University of Edinburgh, Edinburgh EH8 9AG, UK
| | - Aldo Rustichini
- Department of Economics, University of Minnesota, Minneapolis, MN 55455–0462, USA
| | - Veikko Salomaa
- Chronic Disease Epidemiology Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki 00271, Finland
| | - Antti-Pekka Sarin
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland
| | - David Schlessinger
- National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Rodney J. Scott
- Hunter Medical Research Institute and Faculty of Health, University of Newcastle, Newcastle, NSW 2308, Australia
| | - Harold Snieder
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands
| | - Beate St Pourcain
- MRC Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine, University of Bristol, Bristol BS8 2PR, UK,School of Oral and Dental Sciences, University of Bristol, Bristol BS1 2LY, UK
| | - John M. Starr
- Centre for Cognitive Aging and Cognitive Epidemiology, The University of Edinburgh, Edinburgh EH8 9JZ, Scotland, UK,Alzheimer Scotland Dementia Research Centre, The University of Edinburgh, Edinburgh EH8 9JZ, Scotland, UK
| | - Jae Hoon Sul
- Department of Computer Science, University of California, Los Angeles, CA 90095, USA
| | - Ida Surakka
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland,Public Health Genomics Unit, Department of Chronic Disease Prevention, The National Institute for Health and Welfare, Helsinki 00014, Finland
| | - Rauli Svento
- Department of Economics, Oulu Business School, University of Oulu, Oulu 90014, Finland
| | - Alexander Teumer
- Interfaculty Institute for Genetics and Functional Genomics, Department of Functional Genomics, University Medicine Greifswald, Greifswald 17487, Germany
| | | | - Henning Tiemeier
- Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands,Department of Child and Adolescent Psychiatry, Erasmus Medical Center, 3000 CB Rotterdam, The Netherlands
| | - Frank JAan Rooij
- Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands
| | - David R. Van Wagoner
- Heart and Vascular and Lerner Research Institutes, Cleveland Clinic, Cleveland, OH 44195, USA
| | - Erkki Vartiainen
- Division of Welfare and Health Promotion, National Institute for Health and Welfare, Helsinki 00271, Finland
| | - Jorma Viikari
- Department of Medicine, Turku University Hospital, Turku 20520, Finland
| | - Peter Vollenweider
- Department of Internal Medicine, University Hospital, 1011 Lausanne, Switzerland
| | - Judith M. Vonk
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands
| | - Gérard Waeber
- Department of Internal Medicine, University Hospital, 1011 Lausanne, Switzerland
| | - David R. Weir
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI 48106, USA
| | - H.-Erich Wichmann
- Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig-Maximilians-Universität, 81377 Munich, Germany,Klinikum Grosshadern, 81377 Munich, Germany,Institute of Epidemiology I, Helmholtz Zentrum München, German Research Centre for Environmental Health, 85764 Neuherberg, Germany
| | - Elisabeth Widen
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland
| | - Gonneke Willemsen
- Department of Biological Psychology, VU University Amsterdam, 1081 BT Amsterdam, The Netherlands
| | - James F. Wilson
- Centre for Population Health Sciences, The University of Edinburgh, Edinburgh EH8 9AG, UK
| | - Alan F. Wright
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Dalton Conley
- Department of Sociology, New York University, New York, NY 10012, USA
| | - George Davey-Smith
- MRC Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine, University of Bristol, Bristol BS8 2PR, UK
| | - Lude Franke
- Department of Genetics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| | - Patrick J. F. Groenen
- Econometric Institute, Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam 3000 DR, The Netherlands
| | - Albert Hofman
- Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands
| | - Magnus Johannesson
- Department of Economics, Stockholm School of Economics, Stockholm 113 83, Sweden
| | - Sharon L.R. Kardia
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109–2029, USA
| | - Robert F. Krueger
- Department of Psychology, University of Minnesota, Minneapolis, MN 55455–0344, USA
| | - David Laibson
- Department of Economics, Harvard University, Cambridge, MA 02138, USA
| | - Nicholas G. Martin
- Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4006, Australia
| | - Michelle N. Meyer
- Petrie-Flom Center for Health Law Policy, Biotechnology, & Bioethics, Harvard Law School, Cambridge, MA 02138, USA,Nelson A. Rockefeller Institute of Government, State University of New York, Albany, NY 12203–1003, USA
| | - Danielle Posthuma
- Department of Functional Genomics, VU University Amsterdam and VU Medical Center, 1081 HV Amsterdam, The Netherlands,Department of Child and Adolescent Psychiatry, Erasmus Medical Center, 3000 CB Rotterdam, The Netherlands,Department of Clinical Genetics, VU University Medical Centrer, 1081 BT Amsterdam, The Netherlands
| | - A. Roy Thurik
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands,Panteia, Zoetermeer 2701 AA, Netherlands,GSCM-Montpellier Business School, Montpellier 34185, France
| | - Nicholas J. Timpson
- MRC Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine, University of Bristol, Bristol BS8 2PR, UK
| | - André G. Uitterlinden
- Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands,Department of Internal Medicine, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands
| | - Cornelia M. van Duijn
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, the Netherlands,Centre for Medical Systems Biology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Peter M. Visscher
- Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland 4006, Australia,University of Queensland Diamantina Institute, The University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia,Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia,Corresponding author. (D.J.B.); (D.C.); (P.D.K.); (P.M.V.)
| | - Daniel J. Benjamin
- Department of Economics, Cornell University, Ithaca, NY 14853, USA,Corresponding author. (D.J.B.); (D.C.); (P.D.K.); (P.M.V.)
| | - David Cesarini
- Center for Experimental Social Science, Department of Economics, New York University, New York, NY 10012, USA,Division of Social Science, New York University Abu Dhabi, PO Box 129188, Abu Dhabi, UAE,Research Institute of Industrial Economics, Stockholm 102 15, Sweden,Corresponding author. (D.J.B.); (D.C.); (P.D.K.); (P.M.V.)
| | - Philipp D. Koellinger
- Department of Applied Economics, Erasmus School of Economics, Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands,Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands,Corresponding author. (D.J.B.); (D.C.); (P.D.K.); (P.M.V.)
| |
Collapse
|
46
|
Meyer MN. From Evidence-Based Medicine to Evidence-Based Practice. Hastings Cent Rep 2013; 43:11-2. [DOI: 10.1002/hast.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
47
|
Meyer MN. The subject-researcher relationship: in defense of contracting around default rules. Am J Bioeth 2011; 11:27-30. [PMID: 21480072 DOI: 10.1080/15265161.2011.568584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Affiliation(s)
- Michelle N Meyer
- Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics, Harvard Law School, 23 Everett St., Cambridge, MA 02138, USA.
| |
Collapse
|
48
|
Affiliation(s)
- Michelle N Meyer
- Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, USA
| |
Collapse
|
49
|
Abstract
Many assumed that the Obama administration would usher in a sea change from the previous administration by expanding NIH support for human embryonic stem cell (hESC) research and reducing the patchwork of state and federal regulations that currently governs it. This article examines the extent to which NIH's new Guidelines are likely to accomplish these goals.
Collapse
|
50
|
Meyer MN. The kindness of strangers: the donative contract between subjects and researchers and the non-obligation to return individual results of genetic research. Am J Bioeth 2008; 8:44-46. [PMID: 19061109 DOI: 10.1080/15265160802485045] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Affiliation(s)
- Michelle N Meyer
- Georgetown University Law Center and Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA.
| |
Collapse
|